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Kurzbeschreibung 
Die Homöostase der Hämatopoietischen Stamm- und Vorläuferzellen (HSC) in der 
Knochenmark Nische wird von einer Vielzahl exogener Faktoren gezielt reguliert. Diese 
Faktoren orchestrieren intrazelluläre Vorgänge, deren in vivo Analyse kompliziert ist. Die 
vorliegende These widmet sich einem neuen biotechnologischen Ansatz, der systematische 
Studien von Knochenmark-relevanten Faktoren ermöglicht. Im Speziellen wurde die Rolle 3D-
präsentierter Zell Adhäsionsliganden in Kombination mit verschiedenen Konzentrationen 
löslicher Zytokine untersucht. Die Auswertung der Proliferation und Differenzierung von 
humanen HSC auf Einzelzell- und Populationsebene offenbarte die synergistischen und 
antagonistischen Effekte von Adhäsions- und Zytokinsignalen in ihrer Abhängigkeit von der 
Verteilung und der Anzahl von Adhäsionsliganden sowie der Zytokinkonzentration. 
Um die poröse Struktur des Knochenmarks in vivo-ähnlich darzustellen, wurde eine Zellkultur 
Plattform mit Mikrokavitäten verschiedenster Dimensionen von Multi- bis Einzelzellgröße 
entwickelt und mit Molekülen der extrazellulären Matrix beschichtet. Die Vorteile dieser 
Plattform liegen in der  offenen 3D-Geometrie dieses mikrokavitäten Kultursystems, die den 
Zellen ermöglichte verschiedene Wachstumsbedingungen bezüglich Homing, Migration, 
Adhäsion oder Suspension frei zu erkunden. Das leicht zugängliche Setup eignete sich zudem 
hervorragend für die zytometrische Analyse der Zellen oder die quantitative Mikroskopie.  
Die Einzelzellanalyse adhärenter HSC ergab eine Reduktion von DNA Synthese und eine 
höhere Expression von Stammzelloberflächenfaktoren 1  innerhalb der Einzelzell-
Mikrokavitäten bei niedrigen Zytokinkonzentrationen2. Dieser Effekt spiegelte sich auch auf 
Populationsebene in verminderter Proliferation und Differenzierung mit abnehmender Größe 
der Mikrokavitäten wider. Wurde die Zytokinkonzentration jedoch weit über physiologische 
Bedingungen erhöht, verminderte sich der Effekt (reduzierte DNA Synthese und höhere 
Stammzellfaktorexpression) beschrieben für die Einzelzellmikrokavitäten. Dieses Ergebnis 
verdeutlicht die empfindliche intrazelluläre Balance, vermittelt durch Adhäsionsignale und 
löslichen Faktoren, die das Verhalten von HSCs regulieren. Aufgrund des 3D-Charakters des 
Zellkulturträgers wurden innerhalb kleiner Mikrokavitäten mehr Adhäsionsrezeptoren 
ringsum die Zelle aktiviert. Dieser Vorteil gegenüber den Multizellkavitäten oder der 
herkömmlichen 2D–Zellkultur ermöglichte eine hohe Anzahl adhäsionsvermittelter Signale 
mit entsprechend höherer Proliferations-inhibitorischer Wirkung. Je höher die Konzentration 
der Zytokine war, desto stärker erfolgte die  Stimulation der Proliferation und Differenzierung. 
Auf 2D Substraten, initiierte Adhäsion zu Fibronektin und Heparin innerhalb der ersten 24h 
einen frühen Zell-Zyklus-Start im Gegensatz zu nicht adhärenten Zellen. Die Zytokine im 
Zellmedium förderten die Integrin Aktivierung, was zu einer schnellen Zelladhäsion führte. 
Die Adhäsionsrezeptoren wiederum kooperieren mit Zytokinrezeptoren im Zellinneren  und 
begünstigten damit einen zeitigeren Zell-Zyklus- Start. Allerdings stellte sich danach ein 
Gleichgewicht im Kultursystem ein, wobei weniger adhärente Zellen als nicht-adhärente Zellen 
den Zellzyklus durchliefen. Des Weiteren war die Zellzyklusrate innerhalb von 3D 
Mikrokavitäten niedriger verglichen mit herkömmlichen 2D Substraten. Diese Ergebnisse 
                                                     
1 CD34 und CD133 
2 Niedrige Zytokinkonzentration: 10 ng jeweils, hohe Zytokinkonzentration: 30 ng je TPO, SCF, FL3 
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bestätigen  ferner obenstehende These, dass Zytokin‐induzierte Zellexpansion durch  erhöhte 
Zelladhäsions‐vermittelte Signale überschrieben wird. 
Um  die  in  vitro  Studien  zu  komplettieren  wurde  ein  in  vivo  Repopulationsversuch 
durchgeführt.  HSC  kultiviert  auf  Einzel‐Zell‐Mikrokavitäten  übertrafen  frisch  isolierte 
Konkurrenz‐Zellen  in einem kompetitiven Repopulationsversuch. Dieses erste Ergebnis zeigt, 
dass  sich der Zellgröße  entsprechende Biomaterialien  für die  erfolgreiche  Stammzell‐Kultur 
eignen.  
Die Ergebnisse dieser Arbeit bieten eine vielversprechende in vitro Zellkulturstrategie, die ein 
besseres Verständnis  der  Einflüsse  von  exogenen  Signalen  auf HSC  erlaubt  und  damit  eine 
Grundlage für neue Erkenntnisse in Richtung erfolgreicheres Tissue Engineering und klinische 
Anwendungen im Bereich der regenerativen Medizin bildet.     
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Abstract  
The bone marrow (BM) niche provides hematopoietic stem (HSC) and progenitor cells with 
many exogenous cues that tightly regulate homeostasis. These cues orchestrate cellular 
decisions, which are difficult to dissect and analyze in vivo. This thesis introduces a novel in 
vitro platform that permits systematic studies of BM-relevant factors that regulate 
homeostasis. Specifically, the role of 3D patterned adhesion ligands and soluble cytokines were 
studied in a combinatorial fashion. Analysis of human HSC differentiation and proliferation at 
both population and single cell level showed synergistic and antagonistic effects of adhesion- 
and cytokine-related signals. Those effects were dependent on the cytokine concentration and 
the distribution and number of adhesion ligands.   
The aim of this thesis was to model the in vivo bone marrow with its porous 3D structure and 
different sized niche compartments using a microcavity culture carrier. The developed culture 
system presented extracellular matrix (ECM) adhesion ligands to the HSCs in various defined 
dimensions ranging from single- to multi-cell capacity. The 3D open well geometry of the 
microcavity carriers also allowed HSCs to freely explore different scenarios including homing, 
migration, adhesion, or suspension. Furthermore, the developed setup offered straightforward 
accessibility to analytical methods like cytometry and quantitative microscopy. 
Single cell analysis of adherent HSCs showed decreased DNA synthesis and higher levels of 
stem cell marker 3 expression within single cell microcavities under low cytokine conditions 4. 
This effect was reflected in a decline of proliferation and differentiation with decreasing 
microcavity size. When the cytokine concentration was increased2 beyond physiological levels 
the inhibitory effect on proliferation and differentiation due to single-cell-microcavity 
adherence was diminished. This result highlighted the fine balance between adhesion related 
and soluble cues regulating HSC fate. Within small microcavities more adhesion related 
receptors were engaged due to the 3D character of the culture carrier compared to multi-cell 
wells or conventional 2D cell culture plates. This study demonstrated that adhesion-related 
signal activation leads to reduced proliferation and differentiation. This geometry-based effect 
could be reversed by increased cytokine supplementation in the culture media. For plane 
substrates, HSCs attachment to fibronectin or heparin initiated early cell cycle entry compared 
to non-adherent cells during the initial 24h. Cytokine supplemented media favored integrin 
activation that induced fast adhesion, ultimately leading to early cell cycle activation. 
However, after prolonged cell culture the system balanced itself with a lower cycling rate of 
adherent versus non-adherent HSCs. Furthermore, HSCs within the 3-dimensionality of the 
microcavities cycled less than 2D adherent cells. These findings additionally supported the 
above stated idea of limited HSC proliferation as a consequence of more adhesion-related 
signals overwriting cytokine driven expansion. 
To complement the various in vitro studies, an in vivo repopulation study was performed. 
Cultured HSCs derived from single cell microcavities outperformed freshly isolated HSCs in a 
competitive repopulation assay, indicating that carefully engineered substrates are capable of 
preserving stem cell potential.  
                                                     
3 Namely CD34 and CD133 
4 Low cytokine conditions: 10 ng each; High cytokine conditions: 30 ng each TPO, SCF, and FL3 
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Overall the reported findings provide a promising in vitro culture strategy that allows the stem 
cell field to gain a better understanding of the impact of distinct exogenous signals on human 
HSCs, which discloses new concepts for the wide scientific community working towards tissue 
engineering and regenerative medicine.   
  Introduction 
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1 Introduction 
The unique properties of stem cells – self-renewal and differentiation into tissue specific cells - 
offer great potentials for regenerative therapies in medicine.  Stem cells are distinguished by 
their regenerative potential between the all-rounder embryonic stem cells that are able to form 
all cell types and tissue specific adult stem cells. Regeneration after injury and tissue renewal 
e.g. daily blood and intestinal cell formation requires functional adult stem cells. Studies of 
these cells enable the identification of the essential properties yielding therapeutic potential 
unlike specialized cell types. One of the best studied adult stem cell populations are blood 
forming hematopoietic stem and progenitor cells (HSC). Elucidation of the regulation of these 
stem cells is expected to aid the understanding of developmental and repair mechanisms in 
tissues, which are crucial for essential medical procedures such as bone marrow 
transplantation.   
1.1 Motivation 
The main implications for bone marrow transplantation are various hematopoietic cancers, 
such as leukemia and lymphomas, or the high dose chemotherapy for cancers in other organs, 
typically responsible for the eradication of the native blood-forming environment. Further 
indications are genetic or acquired bone marrow failure, e.g. aplastic anemia, thalassemia 
sickle cell anemia, and autoimmune diseases. Therapeutic delivery of sufficient amounts of 
viable HSCs is of critical importance; therefore their successful in vitro expansion remains one 
of the major goals in contemporary hematopoietic research. The development of a culture 
platform for HSCs to control their fate and provide favorable conditions for expansion is 
expected to considerably improve the outcome of ongoing transplantation procedures.   
1.2 Objective 
Inside the bone marrow, a specialized microenvironment known as the ‘stem cell niche’ 
supports maintenance and maturation of HSC [1]. Interaction between HSCs and their niche 
involves the interplay of many factors, including extracellular matrix (ECM) molecules, cell–
cell contacts, and cytokines. This interplay critically balances cell cycling and quiescence, 
leading to proliferation or apoptosis and self-renewal or differentiation [2, 3, 4], respectively. 
Due to this complexity of the in vivo HSC microenvironment the in vitro induction of HSC 
proliferation on a variety of supports mimicking the structural and functional characteristics of 
the bone marrow remains an intriguing conundrum. HSC expand in vivo, but they usually 
differentiate in vitro [5].  Even though HSC are the best-studied adult stem cells the 
reconstitution of the in vivo conditions into the cell culture dish has proved to be quite 
challenging by far [3].  
Understanding the implication of distinct exogenous signals and their orchestration in HSC 
fate decisions is a prerequisite for successful tissue engineering strategies and improving 
clinically-applied cell replacement therapies. But stem cell properties and their fate are 
difficult to prove and track in vivo. 
  Introduction 
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Therefore the aim of this work was to dissect the effect of geometrical constraints and adhesive 
interactions on HSCs during cytokine-driven expansion in an in vitro set-up. For this a set of 
culture carriers with defined micrometer-sized cavities that were 10 µm deep and 15 to 80 µm 
in diameter was prepared and functionalized with bone marrow relevant extracellular matrix 
(ECM) molecules. This setup is aimed to model the in vivo bone marrow HSC niche with its 
highly porous structure [6, 7, 8] and different sized niche compartments, which range from 
single to multi-cell capacity as this parameter is expected to have a high impact on HSC fate 
inside a possible stem cell niche. 
 
Figure 1 Niche Relations.  The objective of 
this work is to gain insight into the 
relation of proliferation and 
differentiation with dependence on matrix 
adhesion and spatial constraints by 
providing experimental tools to analyze 
and control HSC fate decisions  in vitro.  
 
Human CD133+ HSCs from peripheral blood, which are early progenitors [9] with multilineage 
[10] and repopulative capacity [11], were cultured on these ECM-coated microcavity structured 
substrates. Analysis of HSC proliferation and differentiation at both population and single cell 
levels was applied to elucidate the interplay of spatial constraints, adhesive interactions, and 
cytokine concentrations on HSC fate decisions in vitro (Fig. 1). 
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2 Basics 
Stem cells play a central role in an organism. They have the potential to develop into many 
different cell types during early life and growth. Additional stem cells serve as internal repair 
system for damaged tissue and replacement of worn-out tissue. Further on cancer may also 
arise from stem cells going into abnormal proliferation; therefore it is essential to elucidate 
their control mechanisms. 
2.1 Stem Cells and their Role in Life 
Stem cells are distinguished from other cells by two important features. They are unspecialized 
cells capable of self-renewal and they can be induced to differentiate. In some organs, e.g. bone 
marrow and gut, stem cells regularly divide to replace and repair tissue. In other organs, such 
as pancreas and heart, they only divide under special conditions. To accomplish self-renewal 
and/or differentiation stem cells use either symmetric or asymmetric division strategies [12]. 
Symmetric division is defined by the acquisition of the same fate by both daughter cells e.g. in 
the case of self-renewal. Asymmetric division features both stem cell characteristics by 
generating one daughter with stem cell fate and another one that differentiates [13]. It is 
believed that asymmetric cell division of HSCs coincides with primitive stem cell function [14]. 
Two main mechanisms govern asymmetric divisions by regulating the orientation of the 
mitotic spindle: The first ‘intrinsic’ mechanism is based on the asymmetric distribution of 
inner cell components, while the second ‘extrinsic’ mechanism involves the asymmetric 
exposure of daughter cells to external cues [12] (Fig. 2). However, the rare number of adult 
stem cells proves it difficult to technically verify actual asymmetric division via direct imaging.  
 
Figure 2 Stem Cell Divisional Strategies. 
(A) Each stem cell (orange) can divide 
either symmetrically or asymmetrically. 
Intrinsic control of asymmetric division 
includes (B) the assembly of cell polarity 
factors or (C) the segregation of cell fate 
determinants to one daughter cell. These 
factors can be associated with the cell 
membrane, the cytoplasm, centrosome, 
or any other cell component distributed 
between the two daughter cells. (D) One 
daughter cell is retained in the stem-cell 
niche (red) and is maintained as stem 
cell by extrinsic cues whereas the other 
daughter differentiates (green). This may 
also function the other way around by 
exposing one daughter to differentiation 
inducing signals (modified after [12]) 
Different kinds of stem cells are described and worked with in science: pluripotent embryonic 
stem cells (ESCs), non-embryonic multipotent ‘somatic’ or ‘adult’ stem cells, and induced 
pluripotent stem cells (iPSCs). The stem cell potency can be ordered hierarchically (Fig. 3):  
  Basics 
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Totipotent cells are able to build a fully viable organism by forming ESCs and the extra-
embryonic tissue of the blastocyst. Only cells of the first few divisions of a fertilized egg are 
totipotent.  
ESCs are of pluripotent type and derived of the inner cell mass of the blastocyst at a stage 
before it would implant in the uterine wall, self-replicate and give rise to cells from all three 
germ layers (ectoderm, mesoderm, and endoderm) [15].  
IPSCs are adult cells ‘reprogrammed’ genetically to enter an ESC-like state demonstrating all 
important characteristics of pluripotent stem cells, including the expression of stem cell 
markers, the formation of all three germ layers, and the ability to contribute to different tissues 
when injected into mouse embryos at an early stage in development [16, 17, 18].   
 
Figure 3 The Stem Cell Hierarchy. The totipotent zygote formed by the fusion of egg and sperm 
divides to form inner cell mass (ICM) and extra embryonic tissue (EE) of the blastocyst. When 
isolated the cells of the ICM can be maintained in vitro as pluripotent embryonic stem cells. During 
development the ICM cells become increasingly restricted in their lineage potential and generate 
tissue specific multipotent stem cells [15]. 
Somatic or adult stem cells are undifferentiated cells found in differentiated tissue that are 
able to self-renew and generate the cell types of the respective tissue they reside [19]. However 
there are controversy debates that stem cells from one tissue may give rise to cell types of a 
complete different tissue [20], which is referred to as ‘plasticity’ [21, 22]. Sources of adult stem 
cells have been found in the bone marrow, blood stream, cornea and retina of the eye, the 
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dental pulp of the tooth, liver, skin, gastrointestinal tract, and pancreas.  The primary 
functions of adult stem cells are to maintain steady state functioning of their respective tissue 
and replace cells that die because of injury. Adult stem cells are rare (e.g. 1 in 10000 to 15000 
cells in the bone marrow is a hematopoietic stem cell HSC [23]) and in contrast to ESCs the 
exact origin of adult stem cells in any mature tissue remains unknown. Before they reach their 
fully differentiated state, stem cells generate intermediate cells which are called precursors or 
progenitor cells and already regarded as committed [24]. However, these cells are capable of 
undergoing cell division resulting in two different specialized cells. Once adult stem cells are 
removed from the body, their division capacity is limited and further complicating their 
expansion. Methods used for identification of stem cells are; (a) the labeling of cells and then 
to score the cell types they generated and (b) the determination of the repopulation capacity of 
their tissue of origin in another animal.  
Stem Cells and their Niches 
Small regions inside a given tissue are commonly assumed to maintain and control stem cell 
activity [13, 25]. These specialized microenvironments known as stem cell ‘niches’ can be 
defined as three-dimensional spatial structures in which one or several stem cells [26] can 
reside for an indefinite period of time and produce progeny cells while self-renewing [27]. Very 
recent models suggest separate but adjacent niche sites supporting the coexistence of either 
actively cycling or quiescent stem cell subpopulations [25]. 
Despite the growing knowledge, a lot of key questions in adult stem cell research still remain: 
What are the characteristics of the ‘niche’ that control their behavior in vivo [28]? And, how are 
stem cells influenced by these characteristics? Are stem cells instructed by special 
environmental cues to undergo certain fate decisions or are they already determined and only 
permit particular signals to influence them?  
2.1.1 Hematopoietic Stem Cells 
Hematopoietic stem cells (HSCs) are blood forming cells which were recognized more than 40 
years ago [29]. They are capable of self-renewal and give rise to all kinds of blood cells in the 
body. One single HSC may regenerate the entire hematopoietic system of an organism [30]. 
HSC develop into two major progenitor lineages; common myeloid (CMP) and common 
lymphoid progenitors (CLP). CMPs again give either rise to megakaryocyte/erythroid 
progenitors developing into platelet producing megakaryocytes and erythrocytes or 
granulocyte/macrophage progenitors generating mast cells, neutrophils, eosinophils, and 
macrophages. CLPs will mature into B-lymphocytes, T-lymphocytes, and natural killer cells [31] 
(Fig. 4). 
Within adults the majority of HSCs reside in the bone marrow (BM) with few cells constantly 
cycling through the peripheral blood. During development hematopoietic sites are also found 
in the aorta-gonad-mesonephros region, fetal liver, and neonatal BM [32]. For clinical purposes 
usually granulocyte-colony stimulating factor (G-CSF) mobilized HSCs out of the peripheral 
blood are used, since this is less invasive and less painful for the donor than harvesting bone 
marrow. Mobilized cells are passed through a device that separates out cells expressing CD34 
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on their surface and returns the remaining blood to the donor’s circulation. This procedure is 
known as apheresis. 
Many combinations of surface markers have been used to identify, purify, and isolate HSCs 
derived from peripheral blood or bone marrow. Such markers can be tagged with monoclonal 
magnetic or fluorescently labeled antibodies to be selected out of the bone marrow or 
peripheral blood and detected via magnetic cell sorting (MACS) and/or fluorescence-activated 
cell sorting (FACS). Most important markers are presented below (Tab. 1). Lineage marker (lin) 
include 8 to 14 different monoclonal antibodies that recognize surface proteins present on 
differentiated hematopoietic lineages [33, 34]. 
Table 1 Surface marker expression of mouse and human HSCs summarized after [35, 36, 37]. 
Mouse Surface Marker Use Human Surface Marker Use 
lin- present on differentiated 
hematopoietic cells 
lin- present on differentiated 
hematopoietic cells 
Sca-1+ expressed by stem cells and 
progenitors, excludes myeloid-
cell-biased progenitors 
CD34+ expressed by hematopoietic 
stem/progenitor cells, 
endothelial cells 
CD27- member of TNF receptor family 
expressed by many progenitors 
CD38- expressed by myeloid, B- and 
T-cell progenitors, monocytes, 
plasma cells 
CD34- expressed by progenitors CD45+ all hematopoietic cells 
CD90.1 (Thy-1.1)+ lost at the multipotent 
progenitor state 
CD90 (Thy1) hematopoietic stem cells, T 
cells, fibroblasts, stromal cells 
CD117 (KIT)+ expression levels determine 
immaturity of cells 
CD109- T cells, endothelial cells, and 
activated platelets 
CD93 (AA4.1)  highly expressed by fetal HSCs 
and lymphoid progenitors 
CD117+ (c-kit) expressed by hematopoietic 
stem cells and progenitors 
CD135 (FLT3, FLK2) up regulated by short term 
HSCs, lymphoid biased cells 
CD133+ (Prom-1) hematopoietic stem cells, 
endothelial progenitor cells, 
neuronal- and glial stem cells 
CD150 (SLAM)+ specifies long term HSCs if 
used with CD48- and CD41- 
  
 
Typically, the combination of three to five surface markers recognizes functional stem cell 
activity and yields a higher purification of these. Murine hematopoietic stem cells are typically 
isolated for high expressions of stem-cell-antigen 1 (Sca-1) and CD117 (KIT) lacking lineage 
markers (lin) and are therefore called LSK (lin-, Sca-1+, KIT+) subset [2], which may be further 
purified using SLAM marker CD150 [38, 39] and the exclusion of CD34 and CD135 (FLT3) [40, 
41]. For the purification of human HSCs marker combinations such as CD34+ [42], CD133+ [11], 
CD90+ [43] and the exclusion of CD38 [44] and lineage markers may be used [28]. As already 
mentioned, clinical use usually employs only CD34, which is a population enriched for HSC 
and progenitors but still contains other blood cells.  
However, no definite HSC marker or marker combination has been found so far. Recent 
progress in genomic sequencing, genome wide analysis of RNA expression and protein levels, 
and their comparisons among various types of stem cells may be used to identify sets of genes 
defining ‘true’ stemness and specify different stem cell populations [28, 15].  
Methods often used for stem cell identification in vivo are [28]: (1) Molecular markers within 
living tissue get labeled and the specialized cell types generated are determined. (2) Cells 
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removed from one animal are labeled and transplanted into another animal to ascertain 
whether they repopulate their tissue of origin. (3) The gold standard to prove stem cell identity 
are competitive repopulation experiments which assay long term reconstitution and thus self-
renewal potential of putative stem cells [45]. Irradiated recipient mice are injected with a 
constant number of ‘helper’ bone marrow cells (usually recipient cells, just enough to ensure 
survival) mixed with gradually increasing number of donor HSCs of a distinct lymphocyte 
surface antigen (Ly) e.g. CD45 expressed by different alleles can be recognized by specific 
monoclonal antibodies which distinguish between the variants. Myeloid and lymphoid cells 
are identified after 8 to 10 weeks. The repopulation capacity of donor cells is assessed by the 
ratio of donor and recipient HSCs (distinguished via their Ly) and the number of implanted 
donor HSCs. PCR-markers, chromosomal markers, and enzyme markers may also be used to 
distinguish host and donor cells. Serial transplantation in which reconstituted HSC from the 
primary host are transplanted into a second irradiated mouse measures lifespan and expansion 
limits of the stem cells. (4) Immunologically-incompetent mice allow the testing of human 
cells in mice either with or without human fetal bone or thymus implants. Severe Combined 
Immunodeficiency (SCID) or Non-Obese Diabetic (NOD)-SCID mice serve as model animals. 
Frequently used in vitro assays include the Long-Term Culture-Initiating Cell assay (LTC-IC) 
and Cobble-stone Area Forming Cell (CAFC) assays. The LTC-IC measures whether HSCs still 
exist after five to seven weeks culture period which is proved afterwards by their colony 
forming capability (Fig. 12). The CAFC recognizes the ability of HSC to maintain underneath 
stromal cell layer in tissue culture over five to seven weeks 5 easily detectable with light 
microscopy as a dark cobblestone-like patch. Tissue culture approaches are particularly 
convenient when working with human HSCs. 
2.1.2 Hematopoietic Stem Cell Niche 
Of all cell types in the body, blood cells survive for the shortest period of time [28]. Thus the 
life of an organism depends on their replenishment, which occurs in the bone marrow, where 
HSCs reside, self-renew, and differentiate into all the blood cell types (Fig. 4). 
HSCs are constantly regenerated in the BM where they differentiate into all types of mature 
blood cells [1] (Fig. 4). Within the BM, the so called ‘hematopoietic stem cell niche’ is 
suggested to balance the homeostasis of HSCs by acting on homing, quiescence, and 
mobilization as well as regulating apoptosis, proliferation, and differentiation [4].  Many 
factors of the niche microenvironment interplay with HSC behavior such as extracellular 
matrix (ECM) molecules and soluble factors secreted by all cells residing within the bone 
marrow and cell-cell contacts of HSCs with stromal cells and among each other [46] (Fig. 5). 
BM stromal cells, which are discussed to be derived from mesenchymal stem cells (MSC) [47], 
are a mixed non-hematopoietic cell population forming bone, cartilage, fat, fibrous connective 
tissue, and the network that support HSC blood cell formation. 
 
                                                     
 
5 Progenitors grow in culture for shorter times. 
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Figure 4 Hematopietic and Stromal Cell Differentiation © Terese Winslow (assisted by Lydia Kibiuk)[28].   
Inside the bone marrow two sets of stem cells reside: hematopoietic stem cells from which all red 
and white blood cells arise and mesenchymal stem cells which produce chondrocytes (cartilage), 
osteoblast (bone), adipocytes and skeletal muscle. 
Two different sites are suggested and heavily discussed to contribute to distinct niches for 
HSCs within the BM: near the endosteum (endosteal niche) and around sinusoids (vascular 
niche) [2]. Sinusoids are reticular fenestrated venules that allow cells to pass in and out of 
circulation. There is evidence that individual dormant HSCs are located more in niches at the 
endosteum, whereas activated HSCs are in close contact to sinusoids of the BM 
microvasculature [26]. Further speculation is that, HSC simply pass through these sites during 
their constant circulation (see 2.1.3) [48, 49]. However, the influence of either niche site, stem 
cell number, or the possible action of other microenvironments on HSC maintenance and their 
precise bio-molecular composition is not fully discovered yet [50]. Different stromal cell 
populations are thought to contribute to either niche site with mainly osteoblasts and 
osteoclasts collaborating to the endosteal niche and endothelial cells, megacaryocytes, 
reticular cells, and mesenchymal progenitors governing the vascular niche [48]. Though, as 
already mentioned, the uncertainty about the ‘true’ stem cell phenotype and technical 
limitation of single cell imaging in vivo complicates the identification of supporting cells with 
which adult stem cells interact. There is evidence that osteoblasts are involved in niche 
formation: An increase in N-cadherin expressing spindleshaped osteoblasts correlates with an 
increase in HSC number. It was concluded that osteblasts might support HSC through specific 
interactions between N-cadherin and β-catenin [51]. Also, increased Jagged-1 expression 
(osteoblast) and increased Notch activation (HSC) result in higher HSC number [52]. And, 
metabolic death of osteoblasts is followed by subsequent decrease of HSC [53]. But, otherwise 
in vivo conditional depletion of Notch receptor and/or its ligand Jagged-1 [54], or depletion of 
β-catenin [55] is not affecting HSC maintenance [48]. The chemoattractant stromal derived 
factor-1α (SDF-1α) proposed to regulate HSC maintenance and Angiopoietin-1 (Ang-1) 
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conducting HSC quiescence are both expressed by endosteal and perivascular cells [56, 57, 48]. 
Thus, both niche populations devise different but also similar factors that regulate HSC 
maintenance. High concentrations of calcium ions (Ca2+) at the endosteal surface may also 
contribute to the enrichment of HSC at the endosteal niche, as it has been shown that mice 
deficient in the Ca2+ receptor (CaR) do not engraft in the BM [58]. Additionally, HSC lacking 
CaR showed impaired adhesion to the ECM protein collagen I (Col I). Besides cell-cell 
contacts, ECM components associated with either niche site regulate HSC functionality. 
Very recent research provides evidence for an instructed lineage choice of HSCs meaning that 
cell functionality and differentiation are influenced by their surrounding environment [59]. 
However, it is still unclear how gene expression dynamics are generated and controlled by cell-
cell or cell-matrix interactions [60]. An easy to access in vitro stem cell culture platform with 
discrete stem cell ‘niche’ factors as described above in chapter 1.1 would allow for long term 
observation of cells.  
 
Figure 5 Stem Cell Niche Factors [61]. Inside the bone marrow a combination of distinct soluble and 
membrane bound factors and ECM molecules balance HSC homeostasis and regulate their  
divisional behavior. The biomolecular and physical impact of the ECM upon the interplay of 
proliferation and differentiation of HSCs is of particular interest within this work. 
2.1.3 The ECM Relevancy 
The ECM is crucial to mediate cell attachment, migration, and survival [62, 63], but also binds 
to growth factors and controls their diffusion [61]. The three-dimensional network of the bone 
marrow relevant ECM consists of stabilizing collagen fibers of collagen types I and IV, 
proteoglycans containing chondroitinsulfate (CS), heparan sulfate (HS), and hyaluronic acid 
(HA) [64, 65, 66], and non-collagen glycoproteins like fibronectin (FN) or laminin (LN) 
providing recognition sequences for cell adhesion receptors [67, 68]. Most of the data 
concerning the BM ECM composition were obtained from in vitro co-cultures of HSCs and 
stromal cells and the elution of the BM. Both techniques harbor the disadvantage of unknown 
localization inside the BM. A previous study shows the distribution of relevant ECM 
throughout the BM using immunofluorescence with Col I, Col IV, and FN localized to the 
endosteum and Col IV and LN associated with vessels [67]. Additionally, FN was also found 
within the central marrow region but not associated to the vasculature. The different 
allocation of ECM proteins supports the idea of diverse niches inside the BM. Osteopontin 
(OPN) synthesized in osteoblasts is suggested to have constraining effects on the HSC number 
since its absence leads to an increase of stem cells [69, 70]. For proteoglycans, BM and co-
culture elution studies show, as mentioned above, the presence of CS, HS and HA [64, 65, 66]. 
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Rabbit BM elution shows chondroitin-6-sulfate as the predominant glycosaminoglycan (GAG) 
(79 %) and the occurrence of 16 % HA [66]. The characterization of synthesized proteoglycans 
by long-term co-cultures of murine BM cells identified HS as the predominant GAG followed 
by CS [65]. In vitro culture of HSC on immobilized GAGs indicates highly sulfated HS 
especially 6-O-sulfation of the glucosamine residue of heparin (Hep) to be supportive for HSC 
long-term maintenance [71, 72]. The supportive and adhesive functions of GAGs for HSCs 
require the cooperative interaction with growth factors and ECM proteins [73, 74, 71]. The 
adhesion of HSCs to immobilized Hep after rolling under flow conditions supports the idea of 
HS proteoglycans being localized around the BM endothelium and thereby being involved in 
the process of HSC migration to the BM [75]. The glycoproteins thrombospondin and tenascin 
are both expressed during development and in regenerating organs and found in the BM in the 
surroundings of maturing HSCs [76, 77, 78].  
For ECM recognition the cells express respective adhesion receptors. It was found that normal 
murine bone marrow lineage depleted, Sca-1+ cells express a number of adhesion receptors, 
including αL-, α1-, α3-, α4-, α5-, α6-, β1- integrins, L-selectin, CD44, and PECAM [79]. These 
adhesion receptors are not only important for anchoring HSCs, but also promote specific 
downstream signaling and cooperate with growth factor signaling pathways [80, 81]. α4 and 
α5-integrins control HSC proliferation and differentiation either directly or by modulating 
cytokine-induced signals [46] and are essential for bone marrow repopulation after 
transplantation, the so called ‘homing’ and ‘engraftment’ process [82, 83].  
Homing and Engraftment to the BM 
Homing is a highly regulated multistep process similar to the migration of leucocytes to 
inflammatory sites (Fig. 6). This process includes an initial phase of tethering and rolling of the 
cells to the endothelium of vessels via selectins, firm adhesion via integrins, transendothelial 
migration, and chemotaxis through the ECM to the endosteal surface [84]. The next phase 
involves the interaction of surface receptors, such as α4β1 integrins with FN in the ECM and 
vascular adhesion molecule-1 (VCAM-1), and interactions with soluble, membrane-, or matrix-
bound growth factors [84]. The stromal cell-derived factor 1α (SDF-1α) expressed by stroma 
and endothelial cells and its CXC-Motiv-Chemokinrezeptor 4 (CXCR-4) expressed on HSC play 
a key role in human HSC trafficking to the BM microenvironment [85]. SDF-1α induces a rapid 
temporary activation of α4 and α5-integrins enabling the binding of cells to the endothelium 
and their exit from the circulation [86]. Many cell types, including progenitors and mature 
blood cells may home to the BM, but only stem cells engraft in their niche and initiate 
repopulation [87]. A critical cytokine for HSC engraftment and survival in the BM is the stem 
cell factor (SCF, also called KIT-ligand or steel factor), which is expressed by stromal cells. SCF 
is a ligand for KIT (in mice) and accordingly c-kit (in human), a receptor tyrosine kinase on the 
HSC surface. The activation of c-kit is differentially affected by the soluble versus the 
membrane bound isoforms of SCF [88]. Membrane bound SCF seems to enhance maintenance 
of long term hematopoiesis [89, 88] and induces the up-regulation of CXCR-4 expression [87]. 
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Figure 6 Homing and Engraftment of HSCs to the BM 
[87]. The homing process involves the rolling of cells along the vessel walls with the help of 
selectins, then transendothelial passing and migration to the endosteal surface along a chemotactic 
gradient of SDF-1 and engraftment to the niche via integrins and c-kit, receptor for SCF.  
Sensing the Environment 
Studies of SCF stimulated cell proliferation demonstrate that Rac activation is critical for c-kit 
signaling [90]. Rac belongs to the Rho family of small guanosin triphosphate binding proteins 
(GTPases), which interact with specific target molecules controlling actin cytoskeleton 
reorganization, cell shape and polarity to mediate cellular adhesion responses, like migration, 
cell cycle progression, and survival [91]. Rho GTPases have been shown to integrate stimuli 
from tyrosine kinase receptors, chemokine receptors, and integrins [84]. The best studied 
members are Rac, Rho A and Cdc42. In HSCs Rac is activated by stimulation of CXCR-4 via 
SDF-1α, adhesion via β1 integrins, and stimulation of c-kit via SCF – all pathways important for 
stem cell engraftment to the BM niche and retention [90]. Rac and Cdc42 lead to actin 
polymerization at the cell front and cell polarization for directed migration respectively [92], 
and regulate cell cycle progression through mitogen-activated protein kinase (MAPK) 
dependent and independent mechanisms leading to cyclin D1 expression which induces G1/S 
cell cycle transition [93, 94]. In general, for adhesion dependent cells RhoA activity drives actin 
stress fiber formation and focal adhesion formation, increases cell contractility and thereby 
increases cyclin D1 expression and G1 phase progression [95]. Since HSC are not necessarily 
adhesion dependent cells the role of RhoA for HSC engraftment and cell cycling seems diffuse. 
It has been shown that that decreased RhoA activity resulted in defective α4β1 and α5β1 
integrin-mediated adhesion and impaired SDF-1α directed migration [90]. But also, RhoA 
down-regulation increased HSC engraftment and cell cycle progression [96]. The balance 
between the degree of activation of the two RhoA downstream targets ROCK and mDia might 
be responsible for the either G1 progression promoting or inhibiting effect of RhoA [97]. ROCK 
is inhibitory to G1 progression, whereas mDia is stimulatory. Studies in endothelial cells 
suggest that RhoA preferentially activates mDia relative to ROCK, and thereby shifts the 
balance toward cycling. For ROCK activation rather than mDia higher levels of RhoA activity 
are required [98]. Hence, low RhoA leads to increased cell cycling (via mDia). Thus, cell 
attachment and following cell polarization, actin fiber polymerization and focal adhesion 
formation are closely interconnected with the regulation of cell division [97]. For example, the 
shape of HSCs was found to influence the frequency of cycling; among the slow dividing 
fraction more HSC had membrane protrusions compared to rather round and fast dividing 
cells [14]. Slow division in turn is related to a higher repopulation potential [99]. Changes in 
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cell shape alter cytoskeletal organization and with this the nuclear form [100]. Mechanical 
induced changes in nuclear shape can affect nuclear import of transcription factors and initiate 
cell cycling [101]. The other way around, the cell cycle status of HSCs modulates their adhesion 
receptor expression and thereby adhesion and migration behavior [79, 102].  
Neither Rac nor RhoA influence the affinity of adhesion receptors to the ECM but control 
assembly and disassembly and thereby the density of integrins within cell adhesion complexes. 
With this mechanism the cell is able to regulate the strength of the cell-matrix contact and to 
sense elasticity and geometry of the respective environment [103]. Thus, with the help of cell-
matrix adhesions cells may sense the bio-molecular composition of the ECM and also the 
physical and geometric properties of their microenvironment [103]. It has been shown that 
both the specificity of adhesion ligands and the strength and the geometric distribution of cell 
adhesion forces can affect stem cell proliferation and differentiation [104] by regulating cell 
cycle entry (see above). 
Cell adhesion with its complex intracellular signal transduction network [105] is often 
synergizing with signals provided by growth factors [80, 79] via physical linkage of both 
adhesion and growth factor receptors [95]. Once activated, integrins recruit actin adaptor 
proteins (e.g. vinculin, paxillin, actinin, etc. [106]) and phosphoproteins such as focal adhesion 
kinase (FAK) which link to growth factor/ cytokine receptors [95]. HSCs realize this so called 
‘outside in’ signaling via Proline-rich tyrosine kinase 2 (Pyk2) which is a FAK homologue [107].  
In contrast to the adhesion site located FAK; Pyk2 is distributed throughout the cell plasma 
[108] which might at least partly explain the diffuse adhesion behavior of HSC compared to 
adhesion related cell types [107]. On the other hand, growth factor/ cytokine receptors in turn 
can activate integrins, termed ‘inside out’ signaling, and enhance ECM adhesion, which then 
again may influence growth factor signaling [81].  This interplay of adhesion and growth factors 
and their effect on the signaling machinery of the cell influence cell cycle regulation. 
In summary, cell-ECM interactions, receptor and signaling protein activation, and the resulting 
changes in cell shape and tension play an important role in divisional behavior of cells and vice 
versa, which then may affect stem cell self-renewal and/ or differentiation and the action of 
cytokines upon it.    
2.1.4 HSC Relevant Cytokines 
Growth factors, such as cytokines and hormones, are capable of stimulating cellular growth, 
proliferation, and differentiation. Cytokines are cell signaling molecules secreted by cells and 
used for cellular communication, while chemokines are small-sized cytokines which induce 
chemotactic behavior in cells (chemotactic cytokines). 
Within the BM niche soluble factors secreted locally or at a distance regulate HSCs and their 
progeny. The exact signal composition that governs especially self-renewal still remains 
unclear [109]. Some insight has been gained from in vitro studies testing cytokines and their 
contribution on HSC expansion, self-renewal, and maintenance. As already mentioned above 
the chemokine SDF-1 directs HSC homing into the BM niche important for engraftment [85]. 
Numbers of studies have shown interleukine (IL)-11 and IL-6 to maintain HSC activity. In 
contrast, IL-3 induces expansion and differentiation but reduces HSC long-term culture 
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capability [110]. A variety of cytokine ‘cocktails’ have been used to induce HSC cycling for 
expansion. The combination of FMS-like tyrosine kinase receptor-3 ligand (FL3), SCF, and 
thrombopoietin (TPO) has proved to most efficaciously activate HSC cycling with retention of 
self-renewal capacity [86]. SCF is a critical cytokine for engraftment and maintenance of long-
term repopulating cells [111]. Structural similar to SCF is FL3 which acts in a synergistic manner 
with SCF on HSC proliferation and maintenance [109]. Another important factor for HSC 
maintenance is TPO which is also responsible for the regulation of megakaryocyte 
proliferation and differentiation. The only cytokine clinically used is the granulocyte-colony 
stimulating factor (G-CSF). G-CSF stimulates HSC release into the peripheral blood prior to 
apheresis as alternative to the painful bone marrow harvest [112]. 
Many cytokines appear as soluble and membrane bound isoforms inside the bone marrow 
displaying different actions upon cells. For example, the soluble isoform of SCF exhibits a 
rather short term effect on HSC survival since the receptor-ligand complex is subsequently 
internalized and degraded after binding [88]. With sustained high soluble SCF concentration 
this down-regulates surface c-kit expression leading to desensitization and following 
mobilization of HSCs to the peripheral blood [113]. Whereas the membrane bound SCF 
functions as long term survival factor of HSCs as the SCF/c-kit complex doesn’t get 
internalized keeping them inside the BM niche and additionally supporting integrin mediated 
engraftment to the ECM [113]. SCF only functions as a dimer which binds two molecules of c-
kit leading to receptor dimerization and subsequent intracellular signal transduction [114]. 
Cytokines influence the chemotactic movement important for HSC homing (chapter 2.1.3.) 
along the SDF-1α/CXCR-4 axis. For example, HSCs exposed to IL-3 for expansion show reduced 
response to SDF-1α [115] and impaired engraftment potential [82]. In contrast, as already 
mentioned above in 2.1.3, the exposure of HSC to the membrane bound isoform of SCF 
increases CXCR-4 expression [87]. 
As per definition as growth factors, cytokines induce cell cycling. The critical parameter in 
HSC cycling and expansion is the retention of engraft ability and the self-renewal capacity. 
HSCs expanded ex vivo ‘home’ less efficiently to the BM than freshly isolated cells. Transition 
of HSCs from G0 to G1 but not into cell cycle already markedly diminishes repopulation 
capacity in irradiated recipients [116]. Cycling HSCs show reduced engraftment compared to 
quiescent cells [117]. Induction of S-phase entry reduces the functional binding of HSC to the 
ECM due to altered adhesion receptor expression [118]. Expression of α4 and β1 is implicated in 
defective homing as their appearance declines in culture [119]. Synchronized dividing HSCs 
show fluctuating adhesion to FN and VCAM-1 during cell cycle transition with reversibly 
increased adhesion to FN and reciprocal decrease in adhesion to VCAM-1 [120]. Additionally 
mitogenic activated cells shifted from α4 to predominantly α5 dependent adhesion to FN.  
The amounts of cytokines play an important role in HSC maintenance as well. Most of the 
studies concerning the effect of cytokines single or in combination have been done with 
concentrations way above physiologically relevant ones. This may lead to contrary conclusions 
regarding the functionality of cytokines on HSCs. Physiological concentrations of cytokines are 
suggested to be within picogram range [74]. For the experiments presented below the cytokine 
concentrations were chosen just at the lowest level for the cells to be comfortable in culture.  
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2.2 Cell Culture Scaffolds 
In recent years the in vitro investigation of cell-ECM interactions and their effect on cell 
behavior in terms of adhesion, migration, and development has ‘migrated’ from a plane two-
dimensional (2D) unnatural platforms to rather in vivo like three-dimensional (3D) [121] 
distribution of adhesion and growth relevant factors [122]. New imaging devices which allow 
for observation of 3D objects [123] and the development of micro- and/or nanometer sized 
biotechnological setups disclose a number of physiological insights for basic research. 
2.2.1 General 2D, 3D 
Inside the body cells are surrounded by a variety of extracellular cues influencing their 
behavior. Cells sense the geometrical distribution of bio-molecular ligands [122] and physical 
properties like rigidity [124] in a spatial 3D manner. This environmental information is 
transferred to intracellular signaling cascades directing cell survival, proliferation, 
differentiation, and movement [63]. Cells behave differently in response to 3D vs. 2D 
microenvironments not only in terms of adhesion and morphology [121] but also in their 
reaction to biophysical factors [125]. Particularly the rigidity of e.g. cover slips in 2D is a 
component of in vitro systems, which is not present in living tissues. The texture of substrates 
may influence differentiation decisions of stem cells. For instance matrices mimicking brain 
softness induce neuronal lineage specification of MSCs. In contrast stiff collagenous bone-like 
substrates push osteogenic differentiation [124]. In order to study basic cell behavior in 
response to their environment it is essential to provide relevant models. Successful artificial 
substrates are biomimetic viz. they mimic in vivo structures [126].  
To address the issue of a more in vivo like 3D surrounding, encapsulation of cells within 
biological functionalized hydrogels [127] as well as collagen gels have been applied [125]. In 
contrast to these 3D embedding strategies the open well precise geometry of the microcavity 
culture scaffolds presented in this work allows an easy access and escape of HSCs, enabling 
them to freely explore different growth environments in terms of homing, migration, or 
suspension. An additional advantage of the proposed setup is its straightforward accessibility 
to high-resolution analytical methods including cytometry, quantitative microscopy, and 
further functionality assays. 
Apart from basic cell research bioengineered surfaces have found many applications in tissue 
engineering for transplantation and cell-based sensor devices in e.g. drug discovery screening. 
These approaches promise to overcome shortage of transplantable donor material as well as 
more predictive drug discovery processes [128].  
  
  Basics 
22 
 
2.2.2 Substrate Engineering 
Spatially and chemically defined surfaces are fundamental for the precise control and 
interpretation of cellular behavior as cells detect composition, stiffness, and geometry of their 
environment. 
Immobilization of Biomolecules 
The coupling of ECM molecules and growth factors onto cell culture carriers yields a 
promising setup for the investigation and control of HSC behavior. For example cytokines like 
SCF appear not only in soluble fashion but also tethered to cell membranes [129] (see 2.1.4). 
Thus functional immobilization of SCF might lead to long term survival and proliferation of 
primitive HSCs [130].  
Figure 7 Scheme of Biomolecule Immobilization. SCF was immobilized covalently to the poly(octadecene-
alt-maleic anhydride) POMA (A) or to a polyethylene glycol (PEG7) spacer attached to POMA (B). (C) 
Functional Fc-chimeric protein attachment onto PEG hydrogel via ProteinA linkage. Modified after 
[130]and [99], respectively.  
 
Several immobilization strategies are used for surface functionalization: (i) Biomolecules may 
be adsorbed to the desired surface, meaning they are non-covalently bound via electrostatic 
interactions, Van der Waals forces, hydrophobic or hydrophilic interactions, and hydrogen 
bonds.  This is advantageous for the functional activity of the biomolecule or when they need 
to be released on cellular demand. But the nature of the biomolecular tethering might be to 
loose and they get ripped off by cells or diffuse to the media changing buffer concentrations. 
Adsorption is applicable for systems which require release of signaling molecules or matrix 
reassembly by cells. (ii) Covalent binding of biomolecules assures stable attachment but may 
lead to possible sterical hindrances of the active core of the molecule.  Functional groups like –
COOH, -OH, -NH2, and -SiOH are usually applied to tether proteins via their amino-
functionality e.g. side chain of the lysine residue to surfaces. Although the orientation of the 
active core might still be spatially unfavorable the introduction of chemical spacers like poly 
ethylene glycol (PEG) prevents sterical hindrances and assures easier access for cells [130]. This 
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setup is exemplified in figure 7 where SCF was covalently bound either directly to the 
hydrophobic poly(octadecene-alt-maleic anhydride) (POMA) or attached to flexible 
poly(ethylene glycol) (PEG 7) spacer arm tethered to POMA to provide easier accessibility for 
the HSC to compare the action of tethered versus soluble SCF upon receptor c-kit kinetics and 
HSC proliferation. Lutolf et. al achieved functional binding of biomolecules using Fc-chimeric 
proteins which strongly bind to ProteinA modified hydrogel microwells [99](Fig. 7). 
Surface Patterning to Restrict Cellular Adhesion 
Since in vivo ECM molecules and cytokines are not homogenously distributed, but rather 
patterned, micro-structured cell culture carriers are increasingly used in biotechnology [131]. 
Practical applications of micro-patterned cell culture substrates range from tissue engineering 
to cell array based biosensors [132]. The restriction of cellular spreading to a specific surface 
area has been shown to dramatically affect cellular behavior [122, 133, 134]. Protein-resistant 
substrates like PEG-terminated surfaces block protein adsorption from solution as well as 
active adhesion of cells as cell surface molecules are repelled, too. The application of soft 
lithographic techniques allows the geometric patterning of cell adhesive and non-adhesive 
PEG areas [131]. Several PEGs and application options (see chapter 3.4) were used in this work 
to selectively functionalize the microcavities with ECM molecules and passivate the surface in 
between to restrict HSC adhesion to the spatial confinement of the microcavities. 
Defined ECM-coated 3D Microcavities 
For the precise geometrical control of HSCs, micro structured poly(dimethylsiloxane) (PDMS) 
moulds replicated from silicone masters were used in this work. PDMS allows for defined 
structuring down to 100 nm [135] without disadvantageous swelling in aqueous solutions as 
observed for hydrogels [136] or reconstituted collagen [125] during cell culture. PDMS is 
applicable for versatile surface patterning strategies; e.g. microcontact printing that employs 
structured PDMS stamps inked with the desired molecule to create chemically micropatterned 
surfaces [122, 132]. Furthermore, with a chemically modified surface to bind bioactive 
molecules the structured PDMS itself can be applied for cell culture. Such PDMS culture 
carriers may be used e.g. for shape control of single cells [137] or for multicell-arrays [138].  
In this work PDMS moulds with microcavities of different sizes ranging from 15 to 80 µm 
fitting single or several cells were coated with maleic anhydride copolymers to allow the 
covalent coupling of BM relevant ECM molecules [139, 140]. Proteins were directly bound via 
lysine side chains to the anhydride moieties of poly(ethene-alt-maleic anhydride) (PEMA) 
copolymer coating. Hep was immobilised via diaminobutane linkers between the anhydride of 
the copolymer and carbodiimide activated carboxylic acid groups of the GAG (Fig. 9).  These 
homogenously coated (Fig. 13) microcavities were applied to elucidate the interplay of spatial 
constraints, adhesive interactions, and cytokine concentrations on HSC fate decisions in vitro.   
2.2.3 Co-Culture versus the Artificial 3D Niche 
Co-culture with stromal cells has been shown to effectively support HSCs in vitro [141]. Despite 
that, the complexity of these culture systems impedes the identification and modulation of 
microenvironment components such as cytokine concentration or ECM composition. The 
defined three-dimensional HSC culture system presented in this work allows the defined 
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modification and combination of distinct microenvironmental cues to study their effect on 
stem cell maintenance and differentiation in vitro.  
The combined action of spatially constrained adhesive substrates and soluble cytokines was 
investigated with the 3D ECM functionalized microcavity setup upon HSC proliferation and 
differentiation.  
  
  Materials and Methods 
25 
 
3 Materials and Methods 
3.1 Chemicals, Reagents and Equipment 
Table 2: Chemicals and Reagents 
Reagent Company 
Accutase PAA Laboratories GmbH, Pasching, Austria 
ACK Lysis Buffer Invitrogen, Gibco,  Karlsruhe, Germany 
3-Aminopropyl-triethoxysilan Fluka, Deisenhofen, Germany 
Ammonium Hydroxide (29 %) Acros Organics, Geel, Belgium 
Ammonium persulfate (APS) 50 mg/ ml MilliQ freshly 
prepared 
Fluka, Munich, Germany 
4-Arm-polyethylene glycol-hydroxysuccinimide (4-Arm 
PEG-NHS) 
Iris Biotech GmbH, Marktredwitz, Germany 
Bromodeoxyuridine (BrdU) Invitrogen, Karlsruhe, Germany 
Carboxytetramethylrhodamine 
FluoReporter (TAMRA) 
Invitrogen, Karlsruhe, Germany 
CD133 indirect Isolation Kit Miltenyi Biotec, Bergisch Gladbach, Germany 
CellGro medium CellGenix, Freiburg, Germany 
Collagen Type I (Col I) (PureCol) Nutacon BV, Leimuiden, Netherlands 
Collagen Type I Fluorescein isothiocyanate (Col I 
FITC) 
Invitrogen Molecular Probes, Karlsruhe, Germany 
4',6-diamidino-2-phenylindole (DAPI) Sigma Aldrich, Deisenhofen, Germany 
1.4-Diaminobutane (DA) Fluka, Munich, Germany 
Dichloromethane  Acros Organics, Geel, Belgium 
Dimethyl sulfoxide (DMSO) Fluka, Deisenhofen, Germany 
1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) Sigma Aldrich, Deisenhofen, Germany 
Ethylenediaminetetraacetic Acid (EDTA) Cell Culture 
Tested 
Sigma Aldrich, Deisenhofen, Germany 
Ethanol (absolute)  Merck, Darmstadt, Germany 
Ethanol (denatured) Alkoholhandelskontor GmbH, 
Berlin, Germany 
Fetal Calf Serum (FCS) Biochrom AG, Berlin, Germany 
Fibroblast Growth Factor Acidic (FGF-1) mouse R&D, Mannheim, Germany 
Fibronectin (FN) purified from adult human plasma after [142] 
Fluorescein Diacetate (FDA) Fluka, Deisenhofen, Germany 
Fluorescein Isothiocyanate Labeled Hep Invitrogen, Karlsruhe, Germany 
FMS-like tyrosine kinase 3 ligand (FL3) human R&D, Mannheim, Germany 
Glutaraldehyde (GA) Serva Electrophoresis GmbH, 
Heidelberg, Germany 
Heparin (5000 U/ ml) mouse culture Biochrom AG, Berlin, Germany 
Heparin (Hep) Sodium Salt from Porcine Intestinal 
Mucosa Mr 4000-6000(lit.) 
Fluka, Deisenhofen, Germany 
Heparin FITC Invitrogen Molecular Probes, Karlsruhe, Germany 
Heptadecafluoro-1,1,2,2-Tetrahydrodecyl) 
Dimethylchlorosilane 
ABCR, Karlsruhe, Germany 
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Reagent Company 
Heptane Merck, Darmstadt, Germany 
HSC CFU complete with Epo Miltenyi Biotech, Bergisch Gladbach, Germany 
Human Serum Albumin (HSA) 200g/ ml Baxter Dtl. GmbH, Unterschleißheim, Germany 
Hydrochloric Acid Sigma Aldrich, Deisenhofen, Germany 
Hydrogen Peroxide Merck, Darmstadt, Germany 
Insulin-like Growth Factor II (IGF-2) mouse R&D, Mannheim, Germany 
Isopropanol Acros Organics, Fisher Scientific, Nidderau, Germany 
Jeffamine M1000 Huntsman, Everslaan, Belgium 
Loctite 401 Henkel Loctite, Munich, Germany 
Milli-Q Water (MilliQ) purified and deionized water Millipore, Schwalbach, Germany 
Mowiol 4-88 Calbiochem (EMD Chemicals, 
Inc.), San Diego, CA, USA 
N-Hydroxysulfosuccinimide (Sulfo - NHS) Fluka, Deisenhofen, Germany 
N,N,N,N-tetramethyl ethylenediamine (TEMED) 1,5 % 
(v, v) in MilliQ 
BioRad Laboratories, Munich, Germany 
O-[2-(Boc-amino)-ethyl]-O’-[2-(diglycolyl-
amino)ethyl]hexaethylene glycol (Boc-PEG7) 
Fluka, Deisenhofen, Germany 
Paraformaldehyde (PFA) Fluka, Deisenhofen, Germany 
Phenylmethylsulfonylfluoride, PMSF Fluka, Deisenhofen, Germany 
Polyacrylamide (PAAM) pre-gel (37,5:1) BioRad Laboratories, Munich, Germany 
Poly(ethene-alt-maleic anhydride) (PEMA) (MW 
125,000) 
Polysciences Inc., Warrington, PA, USA 
Poly(dimethylsiloxane) (PDMS) Sylgard 184 silicone elastomer kit, Dow Corning, 
Arrow direct, Leipzig, Germany 
Poly-L-Lysine(20 KDa) grafted with Polyethylene 
glycol (2 KDa) having g (Lysine units /PEG chains) = 
3.5 (PLL(20)-g[3.5]-PEG(2)) 
SurfaceSolutionS GmbH, Zurich, Switzerland 
Poly(octadecene-alt-maleic anhydride) (POMA) ( MW 
= 30,000-50,000 g/mol) 
Polysciences Inc., Warrington, PA, USA 
Polyoxazoline M4500 Kind gift from Prof. … TU-Dresden 
Phosphate Buffered Saline (PBS) Dulbecco’s PBS, Fisher Scientific, Schwerte, Germany 
Propidium Iodide (PI) Invitrogen, Karlsruhe, Germany 
Propyl gallate  Sigma Aldrich, Munich, Germany 
Ribonuclease from Bovine Pancreas (RNAse) Sigma Aldrich, Deisenhofen, Germany 
Sodium Hydroxide (NaOH) Merck, Darmstadt, Germany 
Stem Cell Factor (SCF) human Strathmann Biotech AG, Hannover, 
Germany 
SCF mouse R&D, Mannheim, Germany 
StemSpan® Serum-Free Expansion Medium (SFEM) 
Mouse 
STEMCELL Technologies SARL, Cologne, Germany 
Tetrahydrofuran Fluka, Deisenhofen, Germany 
Thrombopoietin (TPO) human R&D, Mannheim, Germany 
TPO mouse R&D, Mannheim, Germany 
Trifluoroacetic acid (TFA)  Fluka, Deisenhofen, Germany 
Trypsin-EDTA Sigma Aldrich, Deisenhofen, Germany 
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Table 3: Antibodies 
Antibody Dilution Isotype/ Clone Company 
anti human    
CD117 APC 1:11 Mouse IgG1 Miltenyi Biotech 
CD133 PE 1:11 Mouse IgG2b Miltenyi Biotech 
CD34 APC 1:11 Mouse IgG2a ÷ 
CD38 FITC 1:11 Mouse IgG2b ÷ 
CD45 FITC 1:11 Mouse IgG2a ÷ 
anti BrdU 1:20 Mouse IgG1 Molecular Probes 
anti mouse    
CD117 APC 1:200 Rat IgG2b/ 2B8 eBioscience, Natutec 
CD34 FITC 1:50 Rat IgG2a/ RAM34 ÷ 
Sca1 PE 1:100 Rat IgG2a/ D7 ÷ 
CD3 biotin (bio)/ APC 1:1000 Hamster IgG/ 2C11 ÷ 
CD19 bio 1:500 Rat IgG2a/ 1D3 ÷ 
NK1.1 bio 1:2000 Mouse IgG2a/ PK136 ÷ 
Ter119 bio/ Alexa750 1:500 Rat IgG2b/ Ter119 ÷ 
CD11b bio/ PE 1:500 Rat IgG2b/ M1/70 ÷  
Gr-1 bio/ Pacific Blue (PB) 1:800 Rat IgG2b/ RB6-8C5 ÷ 
CD45R (B220) bio/ PE/ APC/ PB 1:400/ 100/ 200/ 150 Rat IgG2a/ RA3-6B2 ÷ 
CD45.1 PE-Cy5 1:100 Mouse IgG2a/ A20 ÷ 
CD45.2 Alexa700 1:200 Mouse IgG2a/ 104 ÷ 
Strepatividin PB 1:300  ÷ 
Isotype controls    
iso-PE  1:11 Mouse IgG2b-PE Miltenyi Biotech 
iso-APC  1:11 Mouse IgG2a-APC ÷ 
iso-APC  1:11 Mouse IgG1-APC ÷ 
iso-FITC  1:11 Mouse IgG2a-FITC ÷ 
iso-FITC  1:11 Mouse IgG2b-FITC ÷ 
Secondary Antibody    
goat anti mouse Alexa647 1:200 IgG2a Molecular Probes 
goat anti mouse Alexa546 1:200 IgG2b ÷ 
goat anti mouse Alexa488 1:200 IgG 1 (H+L) ÷ 
Elisa Kits    
c-kit   Cell Signaling 
SCF   RayBiotech 
 
Table 4: Equipment  
Equipment Company 
Cell Counter Casy 1 Schärfe System GmbH, Reutlingen, Germany 
Centrifuge, Heraeus, Labofuge 400R Heraeus Holding GmbH, Hanau, Germany 
Critical Point Dryer CPD 030 Bal – Tec AG, Balzers, Liechtenstein 
FACSAria II (10-fluorescence detectors, 3 lasers: 633 
nm (red), 488 nm (blue), 405 nm (violet) 
Becton Dickinson, Heidelberg, Germany 
FACS Calibur (4-fluorescence detectors, 2 lasers: 
633 nm (red), 488 nm (blue)) 
Becton Dickinson, Heidelberg, Germany 
Gold Sputter SCD 050 Bal – Tec AG, Balzers, Liechtenstein 
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Incubator Hera Cell 150 Heraeus Holding GmbH, Hanau, Germany 
LSR II (12-fluorescence detectors, 4 lasers: 633 nm 
(red), 488 nm (blue), 405 nm (violet), 355 nm (UV)) 
Becton Dickinson, Heidelberg, Germany 
Lyophilisator Lyovac GT2 GEA Lyophil GmbH, Hürth, Germany 
Membrane Pump (55l/ min, N 035.1.2.AN18) Fisher Scientific, KNF Neuberger, Schwerte, Germany 
MilliQ Purification System for deionized water Millipore, Schwalbach, Germany 
Plasma Cleaner PDC-002 Harrick, Ithaca, NY, USA 
Rotary Evaporator Büchi Labortechnik AG, Germany 
Spectral Photometer incl. Magellan Software Tecan GmbH, Crailsheim, Germany 
Spincoater RC5  
 
Süss Microtec AG, Garching, Germany 
Microscopes Company 
Environmental Scanning Electron 
Microscope XL 30 ESEM Philips 
FEI Company, Hillsboro, OR, USA 
Light Microscope Olympus IX 50 Olympus Europa Holding GmbH, 
Hamburg, Deutschland 
  
Laser Scanning Mikroskopes, Leica TCS SP1 & SP5 Leica Microsystems GmbH, Wetzlar, 
Deutschland 
Fluorescence Microscope Leica DMIRE2 Leica Microsystems GmbH, Wetzlar, 
Deutschland 
Axiovert 200 & 200M Zeiss Zeiss, Jena, Germany 
Objectives  
A-Plan 10x/0.25 Ph1 Zeiss, Jena, Germany 
HC PL FLUOTAR 10x/0.30 Leica Microsystems GmbH, Wetzlar, 
Deutschland 
HC PL FLUOTAR 20x/0.50 ÷ 
HCX PL APO 40x/1.25-0.75 ÷ 
HCX PL APO Lbd.bl. 20x/0.70 ÷ 
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3.2 Wafer Design and Surface Functionalization 
A set of silicon masters was designed with square symmetric columns ranging from 15 to 80 µm 
in diameter with respective distances from 30 to 160 µm and 10 µm in height using 
photolithographic etching (GeSiM, Rossendorf, Germany). Later on the silicon masters were 
redesigned with columns of the same dimensions as mentioned above but with a minimum 
distance in between (Fig. 8).  
 
Figure 8 Waferdesign. (A) Represents the design originally used to replicate PDMS microcavities, 
which was later modified (B) to prevent cell adhesion in between the cavities. 
After fluorosilanization ((Heptadecafluoro-1,1,2,2-tetrahydrodecyl) dimethylchlorosilane) of 
the masters (gas phase over night), thin silicone films of poly(dimethylsiloxane) PDMS 
(Sylgard® 184 silicone elastomer kit) were replicated (10:1 curing agent to prepolymer, 5h at 
65 °C) from the microstructured masters. The microstructured silicone moulds were glued 
onto cleaned glass slides (Menzel, Braunschweig, Germany) using a 30 s pretreatment with low 
pressure oxygen plasma of the cover slip and the plane backside of the silicone structures 
(Fig. 9).  
 
Figure 9 Replication of the PDMS Culture Carrier. The freshly mixed two component PDMS is poured 
onto the silanized silicone master (A) and polymerized (B). The cured PDMS structure is then 
peeled off, glued onto a glass coverslip, and coated with the desired ECM molecules (see also 
Fig. 10) followed by HSC culture (C). 
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Thin films of poly(ethene-alt-maleic anhydride) (PEMA) were covalently attached to the 
aminosilanized silicone microstructures as recently reported [139]. Briefly, silicone 
microstructured cover slips were treated for 60 s with medium pressure oxygen plasma and 
placed 2 h into 10 mM 3-aminopropyl-triethoxysilan/ ethanol solution, dried for 1 h/ 120 °C, 
coated with PEMA/ ethanol, dried again 2 h/ 120 °C, and autoclaved (20 min/ 120 °C) to wash 
away unbound PEMA. Prior to FN immobilization, the anhydride moieties were regenerated 2 
h at 120 °C to assure covalent binding of FN [140]. FN purified from adult human plasma by a 
protocol adapted from [142] was diluted to a final concentration of 20 µg/ml in phosphate 
buffered saline (PBS). The PEMA-coated microstructures were then incubated with FN 
solution for 1 h and subsequently rinsed several times with PBS (Fig. 10). Col I was immobilized 
at a final concentration of 0,5 mg/ ml (on ice, 8 parts PureCol, 1 part 10x NaOH, 1 part 10x PBS 
and diluted to 1 mg/ ml with the respective amount of PBS, pH 7,4) for 3 h and rinsed several 
times in MilliQ water. Hep immobilization was achieved using 1.4-diaminobutane as linker 
providing amino groups. Therefore PEMA-coated microcavity cover slips with freshly 
regenerated anhydride moieties were incubated 4 min in 0,1 M 1.4-diaminobutane/ isopropanol 
solution, rinsed 2 x 1 min in MilliQ water, 1 min in 0,01 M hydrochloric acid, and again rinsed 2 
x 1 min in MilliQ water. After drying with nitrogen the formed amide bonds were converted 
into imide groups by reheating cover slips to 120 °C for 2 hours. Immediately after cooling, the 
surfaces were incubated over night with freshly prepared (no older than 5 min!) 1 mg/ ml Hep 
solved in ice cold 0,1 M borate buffer (pH 8,0) containing 200 mM 1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC) and 100 mM N-Hydroxysulfosuccinimide (Sulfo - 
NHS) for carboxylic group activation. Non-bound Hep was removed by rinsing several times 
and autoclaving 20 min 120 °C in MilliQ water. 
To get rid of air bubbles inside the microcavities which are formed during protein coating 
procedure, the microstructured cover slips were placed into an desiccator, covered with PBS 
and degassed (55l/ min), prior to the addition of double concentrated protein solution, which 
is then directly diluted 1:1 on the surface with the degassed PBS. Hep solution was directly 
degassed.  
Prior to cell seeding the surfaces were equilibrated in cell medium w/o additional growth 
factors over night at 37 °C. 
Quality and stability of the coatings were tested using FN fluorescently labeled with 
Carboxytetramethylrhodamine (TAMRA) FluoReporter. The fluorescence intensity was 
checked for seven days by confocal laser scanning microscopy (TCS SP1) while incubating the 
surfaces in 10% fetal bovine serum in PBS to show stability of the immobilized FN against 
displacement by other proteins. For visualization of Col I and Hep coatings, the 
immobilization solution was mixed 1:10 with either Col I FITC or Hep FITC, respectively. 
Additionally Col I fibril formation was controlled with scanning electron microscopy (SEM) 
after drying the surfaces with nitrogen and sputtering a thin layer of gold (60 mA, 25 s). 
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Figure 10 Surface Modification. Proteins are bound via their lysine side chain to the anhydride moiety 
of the PEMA (A). Sugars like Heparin are immobilised via diaminobutane linkers between the 
anhydride of the copolymer and carbodiimide activated carboxylic acid groups of the 
glycosaminoglycans (B). 
Fluorescence intensity was measured using ImageJ software (http://rsbweb.nih.gov/ij/) 
calculating the Mean Gray Value which is the average gray value within the selection (Fig. 15, 
dotted lines in the respective pictures). This is the sum of the gray values of all the pixels in the 
selection divided by the number of pixels.  
3.3 Cell Culture and Analysis 
After obtaining informed consent, G-CSF (10 µg/ kg body weight) mobilized human HSCs from 
peripheral blood of healthy donors were immune magnetically isolated for CD133 positive cells 
after the manufacturer’s instructions (CD133 indirect Isolation Kit, Miltenyi). The 
manufacturer’s protocol was slightly modified: Instead of the recommended 100 µl/ 108 cells of 
FcR blocking reagent/ micro bead solution, and 50 µl/ 108 cells antibody, only 125 µl/ ml and 
62,5 µl/ ml  leucapheresis blood respectively were used. After dilution series this proved to be 
as effective as the recommended amount considering the isolated cell numbers, with lower 
impact on healthy appearance of cultured cells.  The immune magnetic isolation was carried 
out as follows: CD133 positive cells are labeled with a biotinylated monoclonal antibody which 
in a second step was detected by biodegradable streptavidin-coated 50 nm sized magnetic 
micro beads. Cells were further separated on a MACS® column in a MACS® separator which 
generates a magnetic field. The flow through was collected as negative fraction depleted of the 
labeled cells. After the MACS® column was removed from the magnetic field, the retained 
CD133 positive labeled cells were flushed out. Cells were subsequently used for culture and 
flow cytometry.  
Cells were grown in serum-free CellGro medium supplemented with either 10 ng/ ml (low 
cytokine concentration) or 30 ng/ ml (high cytokine concentration) of stem cell factor (SCF), 
thrombopoietin (TPO), and FMS-like tyrosine kinase 3 ligand (FL3). For 14 d cultures half 
medium was exchanged after 7 d. The ‘standard’ setup for the cell experiments was the low 
cytokine concentration (10 ng/ ml). As explicitly stated in the results part of the text, only 
some experiments on cell cycling kinetics were performed at high cytokine concentrations (30 
ng/ ml). The viability of cells was tested using 0.01 mg/ ml  fluorescein diacetate (FDA) and 2 
mg/ ml PI.  
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Freshly isolated cells were directly plated (5 x 104 cells/ ml) onto ECM-coated microcavities 
preincubated with media at 37 °C and cultivated at 37 °C, 5 % CO2). All labeling (FACS, LSM) 
procedures were performed using 10 % FCS/ PBS buffer. 
3.3.1 HSC Culture in ECM-functionalized Microcavities 
On microcavities for proliferation and differentiation studies, HSCs were cultured for seven 
and/ or 14 days on ECM moulds. Non-adherent and adherent cells were collected separately 
after 4 min of trypsinization, counted, washed and labeled for FACS using anti-CD133 
phycoerythrin (PE), anti-CD34 APC and anti-CD38 fluorescein isothiocyanate (FITC) 10 min 
4 °C (see supplements for FACS principle). For immunofluorescence laser scanning microscopy 
(LSM) (SP5, Leica, pinhole completely opened) of adherent cells after seven days, HSC were 
additionally secondary labeled with isotype specific Alexa Fluor 546 and Alexa Fluor 647 goat 
anti-mouse (Invitrogen, 1 h at room temperature) since PE and APC are fast bleaching 
fluorochromes. Alexa Fluor isotype specificity was verified via FACS. 
 
Figure 11 BrdU Incorporation. The thymidine analog BrdU (A) is incorporated in to newly synthesized 
DNA strands during S-Phase of the cell cycle. Though BrdU positive actively cycling cells can be 
detected FACS (B). Counterstaining with propidium iodide allows separation of the cell cycle stages 
G1/Go, S, G2 and M (B, C). 
The cycling kinetics of cells were detected by 20 µM bromodeoxyuridine (BrdU) incorporation 
into replicating DNA during the 24 h preceding fixation in 70% ice-cold ethanol at time points 
of 24 h, three days, and seven days of cell culture. BrdU is a thymidine analogue (Fig. 11 A) 
which gets integrated into the DNA during synthesis (S-phase) (Fig. 11 C). BrdU incorporation 
was measured by FACS for both cells adhering on planar surfaces and non-adherent cells 
(Fig. 11 B). BrdU also was fluorescently visualized for HSCs adhering on FN-coated PDMS 
moulds (Improvision, Leica) after labeling with anti-BrdU and secondary Alexa Fluor 488 goat 
antimouse and counterstained with propidium iodide (PI). Cycling versus non-cycling cells 
were counted using the freely available ImageJ software. For step by step protocol refer to the 
supplements section. 
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For analysis of HSC functionality, colony forming assay (CFU) was performed. Therefore, after 
seven or 14 days of culture on ECM-coated microcavities adherent or supernatant cells were 
separately harvested and plated (500 cells/ surface) into standardized semi-solid media 
supplemented with growth factors supporting colony-forming units-granulocyte-erythroid-
macrophage-megakaryocyte [CFU-GEMM], burst-forming units-erythroid [BFU-E], colony-
forming units-erythroid [CFU-E], colony-forming units-granulocyte-macrophage [CFU-GM], 
and colony-forming units-granulocyte [CFU-G] cells, depending on the potency, which HSCs 
maintained after culture (Fig. 12). Colonies were scored after another 14 days of culture in CFU 
media. 
 
Figure 12 Colony Forming Units. Schematic Diagram of CFU-GM formed by hematopoietic progenitors 
after two weeks incubation. 
3.4 Surface Passivation 
For the passivation of the surface in between the microcavities in order to block protein 
anchorage and force cell to stay within microcavities apart from each other’s potentially 
paracrine stimulation, several blocking approaches were undertaken (Fig. 13). 
Different aminofunctionalized poly(ethylene glycol)’s (PEG) and one polyoxazoline (PMOXA) 
were used, as they are known for their protein antiadhesive properties [143, 144, 131] (Fig. 13).   
In all cases, prior to application of PEG the structured PDMS moulds were coated with PEMA 
as described above (chapter 3.3) and the anhydride moieties were recovered 2 h at 120 °C. The 
PEGs were applied by either stamping (PDMS or poly(acryl amide) (PAAM) stamp), dropping 
or dipping (Fig. 13). For exact solvent concentrations and approaches employed for the 
different PEGs, refer to results chapter 4.1.2.  
  Materials and Methods 
34 
 
 
Figure 13 Used PEGs for Surface Passivation. Four different PEGs were used in different approaches to 
passivate surface in between cavities.  
The PDMS stamps were either used unmodified (blank PDMS) or modified with PEMA, coated 
as described above for the moulds, whereas the anhydride group was not recovered, thus 
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preserving the maleic acid groups and allowing only physisorption of PEG. The PAAM stamp 
was used to try a more wet stamping technique [137] to effectively apply Poly-L-Lysine grafted 
with Polyethylene glycol (PLL-PEG) onto the surface. Therefore 50 µl of 20 µg/ ml PLL-PEG in 
PBS was mixed to 1 ml PAAM pre-gel (30 % acrylamide/ bis solution 37.5:1). Crosslinking was 
initiated with 20 µl ammonium persulfate (APS) and accelerated with 4 µl N,N,N,N-
tetramethyl ethylenediamine (TEMED). The gel was polymerized by dropping 50 µl onto an 
even fluorsilanized silicone master ((Heptadecafluoro-1,1,2,2-tetrahydrodecyl) 
dimethylchlorosilane, gasphase over night in an airtight-sealed petri dish) and putting an 
acrylsilanized cover slip sandwich-like on top for 20 min. After the PAAM gel stuck to the 
acrylsilanized cover slip, the fluorsilanized cover slip could be removed easily with a razor 
blade. Then the structured side of the PDMS moulds was laid on the gel for 15 min loaded with 
a 5 g weight. Prior, the PEMA-coated PDMS moulds with freshly regenerated anhydride 
moieties were either pretreated 30 s with medium pressure oxygen plasma or used directly. 
After, 10 µg/ ml TAMRA labeled FN was incubated 1 h 37 °C to prove passivation via confocal 
microscopy.  
The acrylsilanized cover slips were prepared as follows: Cover slips (Ø 19 mm) were cleaned in 
MilliQ water, ammonium hydroxide and hydrogen peroxide (ratio 5 : 1 : 1, respectively), dried 
in a stream of nitrogen, transformed 2 h with 20 mM acrylsilane in EtOH (abs.) containing 5 % 
MilliQ, washed twice in EtOH (abs.), dried with nitrogen, and annealed for 1 h at 120 °C. The 
cover slips were stored for up to two weeks at 4 °C, prior to use. 
3.5 Mouse Bone Marrow Preparation 
The donor mice (C57BL6 CD45.2, 6 weeks, kindly provided by Claudia Waskow, CRTD) were 
sacrificed and dipped into 70 % EtOH. The femurs from the hind legs were taken, cleaned from 
remaining muscle, and put into 6-well plate in 5 % FCS in PBS on ice for transfer to the sterile 
bench. The bones were cut at each end and the BM was gently flushed out with a 23G 2 ml luer 
lock needle syringe using 5 % FCS/ PBS. The BM was then transferred into a 15 ml tube and 
centrifuged 5 min at 1500 rpm. The supernatant was discarded and cell resuspended in ACK 
buffer for erythrocyte lysis for max. 15 – 20 s. Subsequently 10 ml 5 % FCS/ PBS were added and 
washed another 5 min at 1500 rpm. After discarding supernatant, resuspended cells were 
transferred into 1.5 ml tube with 1 ml 5 % FCS/ PBS counted, washed again, and resuspended in 
5 % FCS/ PBS and kept on ice for short time until further analysis or culture.  
For lineage depletion prior to culture and for preparation of competitor cells, single msBM cell 
suspension was labeled (150 µl per msBM) with biotinylated (bio) lineage antibodies (CD3 bio, 
CD19 bio, NK1.1 bio, Ter119 bio, CD11b bio, Gr1 bio, B220 bio). For Fc block CD16/32 pure and 
rat Ig was used. KLS cells for culture were additionally labeled with CD117 APC (KIT) and Sca-1 
PE. 5% FCS/ PBS buffer was used for dilution (for accordant antibody dilution please refer to 
Tab. 3) and for washing 2mM EDTA was added to the buffer. After antibody incubation for 
40 min on ice cells were washed 2’ at 2000 rpm. One aliquot was taken as positive control. The 
supernatant was discarded and washing repeated twice. The pellet was then resuspended in 
100 µl washing buffer. 5 µl of anti-biotin MicroBeads were incubated for exactly 15’ on ice and 
washed. Cells were resuspended and filtered using filter mesh (pore size 100 µm) and then 
applied onto MACS® column (shortly before usage eluted with buffer/ EDTA) in the magnetic 
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field of the MACS® separator. The negative cells were allowed to pass through and collected 
with subsequent rinsing (3 times 500 µl) of the column. Afterwards the cells were washed and 
incubated with Streptavidin/ Pacific Blue as lineage positive control for another 20’ on ice, 
washed again, and resuspended for FACS sorting. The obtained KSL cells were cultured on 
microcavity culture carriers or used for competitor cells in the repopulation assay. For isotypic 
control and instrument setting #1 aliquot native (unlabeled cells) was taken, #2 was labeled 
anti CD45R PE, #3 CD45R APC, #4 CD45R Pacific Blue (PB), and above mentioned positive 
control was dyed with streptavidin PB. 
Mouse BM cells were cultured on FN-coated microcavities in StemSpan supplemented with 10 
µg/ ml Heparin (5000U/ ml), 10 ng/ ml of each TPO, SCF, fibroblast growth factor (FGF-1), and 
20 ng/ ml insulin-like growth factor (IGF-2)[145] with half medium exchange after 7 d of 
culture. 
For analysis, after 7 and 14 days of microcavity culture cells were detached using accutase 10 
min at 37 °C, washed with 5 % FCS/ PBS, counted, and transferred into v-bottom 96-microwell 
plate for staining with anti-CD117-APC (1:200), anti-Sca-1-PE (1:100), and anti-CD34-FITC (1:50) 
all diluted in 5 % FCS/ PBS. Per microwell 50 µl of antibody solution was used. After 45 min 
incubation on ice cells were washed three times and put into FACS tubes for flow cytometric 
analysis. 
For competitive repopulation lethally irradiated (200 kV, 20 mA, 6.5 min, ≙ 8.5 Gy) eight 
weeks old SJL CD45.1 recipient mice were engrafted. For the first trial 1 x 105 cells from 10 days 
microcavity culture were mixed in equal amount with competitor cells and retro-orbital 
injected in 150 µl 5 % FCS/ PBS into one of three mice each for different microcavity size: # 1 
served as control with cells cultured in suspension, # 2 cells cultured on 15 µm sized redesigned 
microcavities, and # 3 cells from 40 µm redesigned microcavities. To prevent infections 
Neomycin was added to the drinking water (0.295 g/ 250 ml). In vivo repopulation was 
analyzed after 21, 36, 57, and 78 days. Therefore blood was taken from the retro orbital sinus of 
the mice and tested for CD11b (PE), Gr-1 (PB), CD3 (APC), Ter119 (Alexa750), and the ratio of 
CD45.1 (PE-Cy5) and CD45.2 (Alexa700) was assessed Fig. 30) which relates to the contribution 
of microcavity cultured cells to the blood production of the recipient mice. 
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4 Results and Discussion 
4.1 Scaffold Design and Preparation 
4.1.1 Surface Characterization 
For the investigation of spatially constrained HSC proliferation and differentiation ECM 
molecule coated microcavities were used. The microstructured silicone moulds were replicated 
from lithographically designed silicone master structures. ECM components (fibronectin (FN), 
heparin (Hep), and fibrils of collagen I (Col I)) were covalently attached onto the PDMS 
replicas containing cavities of 15 µm to 80 µm in diameter and 10 µm in depth. The surfaces 
were designed to provide the same ratio of microcavity area to total surface area similar for all 
diameters. Redesigned microcavities feature the same cavity dimensions with a distance in 
between as small as possible (Fig. 14). The covalent ECM attachment was achieved using a 
poly(ethylene-alt-maleic anhydride) pre-coating on top of the PDMS scaffolds. In this way, 
proteins can directly be bound via lysine side chains to the anhydride moieties of this 
copolymer coating. Glycosaminoglycans (GAGs) were immobilised via diaminobutane linkers 
between the anhydride of the copolymer and carbodiimide activated carboxylic acid groups of 
the GAGs. The homogeneity, stability, and surface density of the ECM layers was analysed 
using fluorescence microscopy and scanning electron microscopy. 
 
Figure 14 Proof of Surface Quality. Fluorescent images show homogeneous coupling of the ECM 
molecules FN and Col I and Hep. Col I was further analyzed by SEM and showed evenly distributed 
fibrils (insets, scale: 10 µm). The green clusters seen in the fluorescence image turned out to be 
derivates from the FITC staining. In the lower right image HSC adhere to Hep-coated cavities (red 
actin, blue DNA). Scale: 40 µm 
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The FN and Hep coatings were homogeneous inside and outside the microcavities. The Col I 
fibrils were uniformly distributed across the microstructures (Fig.14 and 15). A protein 
displacement assay based on the incubation of coated surfaces with 10% fetal bovine serum 
proved that FN binding was stable after 24 h incubation (Fig. 15) [146] and thus suitable for 
long term cell culture. 
 
Figure 15 Surface Homogeneity and Stability. Immunofluorescence images and surface density plots 
show homogeneous and similar distribution of FN (red) before and after 24 h. The intensity plot 
displays similar values for both time points. (Dotted lines indicate section taken for intensity plot, 
scale 80 µm)   
The amount of immobilized FN was analyzed previously [147] using HPLC based amino acid 
analysis of the hydrolyzed protein 24 h after surface coupling and after exposure to protein 
displacement solution (see above) [146]. Hence, the deployed immobilization solution of 
20 µg/ ml FN results in a surface concentration of 226 ng/ cm2 which approx. equates to the 
theoretical monolayer concentration of roughly 250 ng/ cm2 when considering tightly packed 
FN molecules with their long axis parallel to the surface  [148, 146]. Therefore a FN ligand 
density of 6.13 x 1011 per cm2 can be calculated. The surface density of Hep as determined afore 
using X-ray photoelectron spectroscopy (XPS) can be estimated to 5.6 ± 0.5 x 1014 disaccharide 
units/ cm2  [148].  
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4.1.2 Surface Passivation 
Besides the redesign of microcavities (see below 4.1.3) with higher density another approach 
was implemented to spatially confine the cells inside the microcavities. The chemical 
modification of the surface in between microcavities was aimed by passivation with PEGs 
known to repel protein binding due to their hydrophilic nature [143, 144, 131]. Such PEG 
passivation strategy would also abate the probability of cell-cell communication as assumed 
within redesigned microcavities (chapter 4.3.2). 
Approaches for Surface Passivation 
Several approaches were undertaken to prevent protein binding in between microcavities: 
(i) The Jeffamine M1000 is a relatively short PEG with an amino functionalization at one end 
of the PEG chain for covalent linkage to the anhydride of the PEMA and a methyl group at 
the other end to prevent protein adsorption. 
(ii) The PLL-PEG with its-amino terminated lysine groups was expected to densely cover the 
PEMA in between microcavites for successful protein blocking. 
(iii) The 4-Arm-PEG-NHS is a branched PEG with 4 methyl group terminated end chains and 
was therefore considered to be more effective to block protein binding in between 
microcavites.  
(iv) The PMOXA is considered as a good alternative for PEG with an end-standing methyl 
group to prevent unwanted protein binding [149]. 
Efficiency of Surface Passivation  
After PEG application the microcavity moulds were coated with fluorescently labeled FN to 
prove the passivation of the protein via fluorescence microscopy and intensity measurements.  
(i) Jeffamine M100o was applied to the surface in between microcavities using different 
application and solvent strategies: Jeffamine M1000 was either solved in H2O or in ethanol. 
Stamping using a PEMA modified or non-modified flat PDMS stamp was not sufficient to 
completely block protein binding (Fig. 16 A & C). Streaky patches of FN were still visible, which 
would allow for cell adhesion. To increase passivation efficiency the PDMS mould was turned 
around and dipped into a flat drop of Jeffamine M1000 solved in H2O (Fig. 16 B). Even in that 
case, the blocking was incomplete and PEG partially diffused into the microcavities as the 
fluorescence intensity inside was diminished. In a last trial, a drop of Jeffamine M1000 was 
incubated in different concentration onto the microcavity structures for different duration. 
Low Jeffamine M1000 concentration (5 mM) was not sufficient to prevent protein binding. But 
with further increase of Jeffamine M1000 concentration (10 mM) the surface tension became 
too low; the solution entered microcavites, and thus also blocked protein linkage inside the 
cavities. However, the best FN blocking results were achieved using 5 mM in EtOH and a 
modified stamp (Fig. 16 C).  
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Figure 16 Approaches for Surface Passivation with JeffamineM1000. The PEG in different concentrations 
and solvents (see respective picture) was either stamped with PEMA modified (A), unmodified (C) 
PDMS, dropped onto the microcavities (D), or the microcavity mould was turned around and 
dipped into a flat drop of JeffamineM1000 solution (B). The best blocking of FN was achieved by 
applying 5 mM JeffamineM1000 solved in EtOH via a PEMA modified stamp. Scale 40 µm, FN-
TAMRA red. 
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(ii) Very recently the PLL-PEG was found to be most effective in preventing unwanted protein 
adsorption [137, 132, 150]. However in our case, the PLL-PEG approach for blocking the surface 
area between microcavities didn´t satisfactorily block protein binding (Fig. 17). 
 
Figure 17 Application of PLL-PEG for Protein Repulsion. Adsorption of PLL-PEG (A) solved at 1 mg/ml 
in HEPES buffer with different pH values using a PDMS PEMA modified stamp applied onto PEMA 
coated surfaces (60 min) was first tested via XPS (B). After stamping procedure the surface was 
washed with either H2O or HEPES at pH 10.5 and then autoclaved or not autoclaved. The 
concentration of N atoms was highest for stamping PLL-PEG at basic concentration of pH 10.5 and 
was not affected by autoclaving the samples afterwards. (C) Despite, the surface coverage of PLL-
PEG was not enough to block FN binding even though a wetter stamping technique [137] using 
PAAM hydrogel was tried. Fluorescence: FN-TAMRA red, z-section. 
(iii) The protein blocking capability of 4-Arm-PEG-NHS was first tested on plane surfaces 
using the dropping or stamping method, and washing with different pH 1/15 M phosphate 
buffers (for detailed procedures see Fig. 18 A). The PEG was solved on ice as described by the 
manufacturer in 1/15 M phosphate buffer. 
The best FN blocking results with fluorescence intensity similar to the negative control were 
found for the 5 mg/ml drop incubation and washing with H2O (Fig. 18 B). However, culture of 
adherent 3T3 fibroblasts demonstrated that the surface is still adhesive for cells (Fig. 18 C). 
Thus the 4-Arm-PEG-NHS was not further tried for the microcavity scaffolds. 
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Figure 18 Surface Passivation Approaches with 4-Arm PEG-NHS. (A) The different approaches applied 
are described. FN blocking similar to the negative control was achieved by dropping 5 mg/ ml 4-
Arm-PEG-NHS in 1/15 phosphate buffer and washing with H2O (B). But passivation was not 
sufficient to prevent fibroblast adhesion (C). Scale 40 µm, FN-TAMRA red, Actin green, and DAPI 
blue. 
(iv) As PEG coatings have been reported to degrade and show decreased long term stability 
with functional loss in vivo [151] a potential non-cytotoxic [152] polymer alternative to PEG 
namely poly(2-methyl-2-oxazoline) PMOXA with equal protein-repellent properties to PEG 
coatings [149] was tested for surface passivation in between the microcavities. The amino 
terminated PMOXA had high FN TAMRA blocking capabilities with mean gray value intensity 
below 10 (Fig. 19). However, the even more hydrophilic properties of PMOXA compared to PEG 
led to diffusion into microcavities and rejection of protein coupling inside. 
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Figure 19 Surface Passivation with 
PMOXA. The PMOXA solved at 4.5 mM in H2O was applied to the surface either by turning around 
the microcavity scaffold and dipping it into PMOXA aqueous solution or by dropping PMOXA onto 
the mould. Fluorescence intensity analysis of FN TAMRA coupling shows high efficiency of protein 
blocking. But PMOXA solution also diffused into the microcavities and prevented protein coupling 
inside. 
Only optimal grafting conditions (like grafting density, solvent quality and molecular weight) 
of PEGs were found adequate to successfully avoid protein binding. For instance, too low 
solvent concentration was not enough to completely cover the surface area whereas the high 
concentrations led to sterical hindrances of the molecules and thereby averted sufficient 
surface coverage.  
In summary, thin films of PEGs or other protein repellant polymers might not be appropriate 
to completely passivate surfaces for protein adsorption and to further prevent cell adhesion as 
cells might sense minimal amounts of ECM for attachment [133]. Hence, a thicker gel-like PEG 
layer might be more qualified as protein repellant and will be investigated in future.  
4.1.3 Redesigned Microcavities 
For more quantitative analysis of the HSC proliferation and differentiation inhibiting effect of 
matrix under spatial restrictions, the microcavity setup was redesigned since chemical surface 
passivation was not sufficient (see 4.1.2). The distance in between the microcavities was 
reduced to a minimum, which forces the cells to adhere inside (Fig. 20).  
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Cell experiments were repeated inside these redesigned microcavities comparable to the 
experiments in standard microcavities described in 4.2. Additionally, the CFU-GM forming 
capability of microcavity cultured cells was measured. 
 
Figure 20 Redesigned Cavities. To prevent cell growth in between the cavities (A) moulds were 
redesigned (B) with microcavities side by side thus cells necessarily adhere inside. 
4.2 Summarized Discussion of the Surface Passivation 
The selective patterning with cell active biomolecules is one the major goals of biomaterial 
engineering in order to improve cellular bioassays for basic understanding of the action of 
different molecules on differentiation, proliferation, and signaling pathways. As already 
discussed above, the commitment of stem cells depends on their shape and also on their three-
dimensional adhesiveness. The selective functionalization of single cell constraints would be 
the premise to exclude cell-cell communication or paracrine signaling. Additionally, as 
suggested by Trumpp et al dormant adult stem cells might home to single cell niches [26].  
The soft lithographic techniques presented above (chapter 4.1.2) are not sufficient to effectively 
block surface binding of proteins. Hence, thicker protein-resistant layers might be applicable, 
e.g.  PEG hydrogels coated onto the area in between microcavities. Full hydrogel replicas of the 
microcavities are only suitable for bigger multi-cell cavities (> 100 µm) as hydrogels swell in 
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aqueous environments [136]. Hydrogel stiffness additionally influences stem cell differentiation 
behavior. The stiffness can be adjusted and used for pushing stem cells into the desired lineage 
as described for MSC differentiating into neurons on soft brain like tissue or forming bone on 
an adequate bone-like hard gel [124]. However, due to its fore-mentioned swelling properties it 
is not applicable for single cell cavity design but might function as thin layer gel on top of 
PDMS microcavities. Nanoplotting 6 techniques are further alternative to be used in bigger 
cavities. Due to wetting effects the spotted area will always be greater than 50 µm. Another 
approach would be the dipping of the silicone master pillars into protein solution prior to 
PDMS replication. Thus the desired protein stays within microcavities [153]; however, the 
activity of the protein might be impaired when it is enclosed in the cured PDMS. Likewise Fc-
chimeric Proteins were embossed into hydrogel microwells [136]. Therefore PEG-modified 
ProteinA was inked to the pillars of a PDMS master. During hydrogel casting the ProteinA was 
transferred to the gel matrix and covalently attached via the PEG linker. Subsequently after gel 
curing the desired Fc-chimeric protein was incubated and bound selectively to the microwells.  
In future hydrogel microcavites and nanoplotting techniques should be explored for the 
generation of selectively patterned microcavities to influence and elucidate stem cell fate 
decisions.  
4.3 HSC Culture inside Microcavities 
The three-dimensional arrangement of ECM assemblies in the bone marrow niche serves as 
scaffolding for HSCs and plays an important role in triggering their fate decisions [105, 154]. In 
this context, specific interactions between HSCs and ECM components may initiate 
proliferation and differentiation [3, 155] and were thereon investigated. 
Cell numbers and expression of CD133 and CD34 HSC surface markers were determined by 
flow cytometry after seven days of culture on plane substrates (serving as control) and 
substrates with microcavities of different dimensions.  
In general, HSC viability on all substrates was very high, with over 99% for FACS gating and 
approximately  90% for immunofluorescence analysis (Suppl. Fig. 33 and  34). 
4.3.1 HSC-ECM Interaction Reduces Proliferation 
First analysis of HSC-ECM interactions on plane ECM (FN, Col I, and Hep) -coated substrates 
showed reduced proliferation with the least expansion on FN. The differentiation pattern 
appeared to be similar, independent of the presence of matrix molecules (Fig. 21). For the case 
of FN previous reports explain this finding by showing that adhesion through α4-integrin to 
the heparin binding domain of FN decreased proliferation by inhibitory signaling [156]. This 
might be also the case for other matrix molecules as it has been shown that HSC adhesion to 
ECM secreting stroma osteoblasts reduces proliferation and maintains an immature state [157]. 
Reduced HSC proliferation due to adhesion-related signaling was expected to possibly alter 
differentiation, but the differentiation pattern appeared to be similar independent of the 
presence of the distinct matrix molecules on plane substrates (Fig. 21). 
                                                     
6 Equipment for handling of liquids in submicroliter range for automatic dispensing of micro drops e.g. for micro 
array design 
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Figure 21 Proliferation and Differentiation of HSCs on planar ECM Coated Surfaces. (A) Proliferation 
increases over time with reduced proliferation of HSC exposed to matrix molecules on plane substrates 
compared to control cells in suspension. (B) The differentiation pattern is similar comparing different 
culture conditions (Data are presented as mean ± SEM). 
4.3.2 Population-wide Proliferation and Differentiation of Spatially 
Constrained HSCs  
After seven days of culture on substrates with microcavities of different dimensions the non-
adherent and adherent cell fractions were separately harvested from the surfaces and analyzed 
for CD133 and CD34 HSC surface marker expression.  
HSCs Cultured on Microcavities with Distance in Between  
In general, HSC expansion was reduced on ECM-coated microcavities (0.5- to 3-fold expansion 
for FN and Hep, only 1-fold for Col I) in comparison to the 5-fold expansion seen for the 
control cells on standard tissue culture plastic (Fig. 22 A). After comparing the different cavity 
sizes the most pronounced decrease in total cell expansion rate was detected in the smallest 
microcavities for all three used ECM components. For FN substrates proliferation inside the 
smallest microcavity (15 µm in diameter) fitting only one cell drastically inhibits proliferation 
whereas the bigger sized cavities support HSC expansion in similar manner. Therefore, the 
greater engagement of adhesion receptors of HSC adhering inside the small FN microcavities 
might influence the above described behavior. On Hep-coated microstructures HSC 
proliferation seems to be highest in intermediate-sized microcavities (30 and 40 µm in 
diameter). Previous studies show that adhesion of HSCs to Hep is not as prominent as for FN 
or Col I [158] and therefore cell-cell contacts which are enhanced inside these intermediate-
sized microcavities may play a stronger role possibly boosting proliferation. HSCs cultured on 
Col I fibril surfaces only show a slight increase in proliferation with increasing microcavity size. 
Since Col I fibrils already display a certain three-dimensionality HSC sensing of the spatial 
confinement by microcavities is presumably an aftermath of the overlapped effect of both 
factors.  
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Figure 22 Differentiation of HSCs on ECM Microcavities. (A) The proliferation of HSCs cultured on 
ECM coated microstructured surfaces was reduced when cultured on small microcavities after 7 
days. CD34 and CD133 marker expression showed a higher fraction of undifferentiated cells in the 15 
µm cavities. (B) Segregation of the adherent and supernatant cells reveals a higher ‘stemness’ of the 
FN and Col I adherent cells. No effect on the CD surface marker was observed for Hep surfaces. 
‘Input’ cells are freshly isolated cells and data are presented as mean + SEM; n=3-8. 
Overall, reduction in differentiation was found for cells cultured on Hep and Col I surfaces as 
they show higher rate of stem cell marker expression (93.7 % for Hep, 97.8 % for Col I) rather 
than on FN with 85.9 % stem cell marker expression. Only on the smallest (15 µm) FN-coated 
microcavities 96.1 % of cells express CD marker. Thus, matrix molecules presented in a three-
dimensional manner distinctively influence differentiation behavior of HSCs. 
When segregated, FN- and Hep-adherent versus non-adherent cells in the respective 
supernatant show the same proliferative trend as described above. But the number of CD 
marker negative cells adhering to FN is half compared to cells in the supernatant. Hence, 
adhesion signals provided by FN seem to supress differentiation of progenitors. It has been 
suggested that adhesive interactions of HSCs to FN regulate proliferation and differentiation of 
HSCs [46]. FN is implicated in the homing process [82] and its receptors α4- and α5-integrin 
have been shown to control proliferation and differentiation either directly or through 
modulation of cytokine signaling [159, 160, 161]. Thus engagement and additionally the number 
of engaged adhesion receptors might play a regulatory role in maintaining a more quiescent 
state of HSCs. This assumption will be further addressed in the following chapters of this work. 
No impact of Hep-adherence compared to cells in suspension was found regarding cell 
differentiation. GAGs in vivo are mainly associated to proteins, hence rather displaying their 
action on cell behavior in combination. Additionally, as already mentioned above, adhesion 
receptor anchorage is not as strong as for protein ligands [148]. 
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Col I adherent HSCs increase in number with increasing microcavity size whereas cells in the 
respective supernatants show an opposite trend. Furthermore the number of more primitive 
cells expressing both CD34 and CD133 marker is 2-fold greater for adherent HSCs compared to 
supernatant cells.  Thus Col I adherence contributes to a more immature state of HSCs, too. 
The effect of Col I on HSC differentiation or proliferation has not been described yet. But the 
fact that HSCs specifically adhere to Col I [158] and that it is one of the major components of 
the bone marrow maintaining immature HSCs [67] implies a differentiation and proliferation 
decelerating role. 
HSCs within Redesigned Microcavities 
For a more quantitative evidence of the above stated differentiation and proliferation 
decelerating role of the confining of HSCs, PDMS moulds were redesigned to force cells to stay 
within microcavities (Fig. 20). After 7 and 14 days of culture on substrates with redesigned 
microcavities of different dimensions the non-adherent and adherent cell fractions were 
separately harvested from the surfaces and analyzed for CD133 and CD34 HSC surface marker 
expression as described above.  
As described for the scaffolds with defined dimensions in between the microcavities 
proliferation is reduced inside small single cell microcavities for FN and Hep after 7 days of 
culture. For Col I a reverse effect appears with higher proliferation inside smaller cavities (Fig. 
23 A). When separately examined the adherent cell fractions don´t show any dependence on 
the size of the spatial confinement regardless of the presented ECM (Fig. 23 B). The trend seen 
in the overall cell culture studies with reduced proliferation when cultured on small 
microcavities (for Col I vice versa) can only be observed within the supernatant cell fraction. 
However, the ratio of CD34 marker expression is higher when HSCs are adherent to the 
scaffolds approximately 90 % for all surfaces compared to approximately 80 % for cells in the 
supernatant. The effect seen for small Col I microcavities might be explained by the process of 
surface preparation; The Col I solution is probably too viscous to enter each of the smallest 
15 µm microcavities and the fibrils are often longer than 15 µm thereby building a planar 
carpet-like network of Col I fibrils.   
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Figure 23 Differentiation after 7 Days of Culture on Redesigned Microcavities. (A) Overall Proliferation 
is increasing with larger microcavities for FN and Hep surfaces, whereas for Col I the reverse effect 
can be observed. (B) Segregation of adherent and supernatant cells shows reduced proliferation but 
also less CD marker negative cells for ECM bound cells compared to supernatant cells. Data are 
presented as mean + SEM, n=4. 
After 14 days in microcavity culture overall proliferation rate is similar for FN and Col I 
cultured cells (12-fold) and slightly lower on Hep (10-fold) (Suppl. Fig. 35 A). Expansion of CD 
marker expressing cells doesn’t show any dependency on microcavity size. Segragation of 
adherent and supernatant cells again shows less CD marker negative cells for the adherent 
cells and thus the same absolute number of CD marker expressing cells for FN and Col I 
surfaces and their respective supernatant (Suppl. Fig. 35 B). On Hep surfaces adherent HSCs 
show almost no expansion which might partly be explained by the technical procedure of cell 
removal from the culture for analysis.  HSCs growing on Hep have a relatively small adhesion 
area [158] compared to cells adhering to FN or Col I. This might account for the lower adhesion 
strength and result in the easier washing off the cells when taking out the supernatant fraction. 
However, the ratio of CD marker expressing cells within the adherent cell fraction is similar as 
for FN and Col I with approximately 60 % compared to 50 % in the supernatant (Suppl. Fig. 35 
B). This proves the above discussed differentiation decelerating role for HSC-ECM-adhesion 
related signaling. The proliferation inhibitory effect of small microcavities as described in 4.2.1 
for the cavities with distance in between is not as pronounced for the redesigned cavities but 
cognizable for FN- and Hep-coated surfaces. One reason might be the close proximity of cells 
sitting in neighboring microcavities. The cells possibly still sense each other and thus promote 
each other’s cycling via paracrine signaling [162] which was also observed for the intermediate-
sized Hep microcavities described in 4.2.1.  
Therefore both microcavity designs functionalized with FN were compared directly for overall 
proliferation after 7 days of culture using the same donors. Surprisingly, no dependency of 
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proliferation upon microcavity size was seen for the cavities with distance in between. For the 
redesigned microcavities proliferation was reproducibly reduced with decreasing cavity size 
(Fig. 24). Although paracrine signaling cannot be ruled out for redesigned cavities, it might not 
be the major contribution, and HSC show reduced proliferation with decreasing microcavity 
size.  
Figure 24 Comparison of 
Different Cavity Designs. Microcavities were functionalized with FN and cultured with HSCs from 
the same donors for seven days. The proliferation of cells growing on cavities with distance in 
between doesn´t show any dependency on the microcavity size. On the contrary, within redesigned 
cavities, the proliferation decreased with decreasing microcavity size. Data are represented as mean 
+ SEM, n=5.  
4.3.3 Colony-forming Ability of Microcavity Cultures 
To score the potency of in vitro microcavity cultured HSCs colony forming unit capability was 
assessed. After 7 or 14 days of culture on ECM-coated redesigned microcavities, cells were 
plated into methylcellulose medium which contains a complete mix of cytokines and growth 
factors to promote forming of colony-forming units-granulocyte-erythroid-macrophage-
megakaryocyte [CFU-GEMM], burst-forming units-erythroid [BFU-E], colony-forming units-
erythroid [CFU-E], colony-forming units-granulocyte-macrophage [CFU-GM], and colony-
forming units-granulocyte [CFU-G] depending on the potency HSC maintained after culture 
(Fig. 12). 
HSCs were grown for 7 or 14 days on ECM covered microcavity culture carriers, detached and 
adherent and supernatant cells were separately cultured in CFU media by equal number of 500 
per cell fraction. CFUs were scored after 14 days. 
For HSCs cultured in suspension the CFU forming capability decreased with increased time in 
culture and decreasing CD34 and CD133 marker expression (Fig. 25). Especially the CFU-G and 
CFU-E forming units were reduced after 14 days in culture. 
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Figure 25 Colony Forming of HSCs Cultured in Suspension. With increasing time in culture and 
decreasing stem cell marker expression the number of CFU decreases to one half after 14 days. Data 
are represented as mean + SEM, n=5.  
For the microcavity adherent cells the ratio of CD marker expression is higher compared to 
supernatant cells (Fig. 26 A), it was expected that the CFU forming capability of formerly ECM 
attached cells is higher than for suspension cells. 
After 7 days of microcavity culture cells show similar numbers of CFUs when scored for all 
surfaces independent of matrix coating and microcavity size (Suppl. Fig. 36).  
To exclude the contingency, those 7 days of microcavity culture are too short that the effects 
observed for the CD marker expression is reflected within the CFU forming profile, HSC were 
cultured additional 7 days and then scored for CFU capability.  
Overall CFU forming after 14 days of microcavity culture was reduced to one half as compared 
to after 7 days. This correlates to the decrease in surface marker expression profile (Fig. 26 and 
Suppl. Fig. 36). The CFU-M stayed similar with approximately 18 colonies per surface and CFU-
E was drastically reduced from approximately 23 colonies to 4 colonies per surface as also seen 
for control cells in suspension (Fig. 25). This suggests that the selected set of surface markers 
tested here correlates well with the CFU potency of the cells with the exception of GFU-M 
which is not related to the CD34/133 expression and possibly a potency kept throughout longer 
term differentiation.  
Unexpectedly colony forming was reduced within the surface adherent cells although the stem 
cell CD marker expression according to the FACS profile is higher compared to supernatant 
cells (Fig. 26 A). For FN and Col I the CFU potency was even decreased inside small single cell 
microcavities which have been shown from FACS profile to maintain stem cell marker 
expression. One possible explanation might be the trypsinization of adherent cells for surface 
detachment since supernatant cells weren’t treated with trypsin (Suppl. Fig. 37). Although cells 
were recovered in 10% FCS/ PBS and no profound effect was found for the cytometric profile, 
  Results and Discussion 
52 
 
the trypsinization procedure probably affects HSCs, which is only seen in long term culture. 
Flushing the cells off the surfaces and ripping them out of the microcavities, although 
performed as gently as possible is a quite harsh procedure which probably further influences 
long term survival and potency of HSCs. This also applies for collagenase-treated cells 
detached from Col I microcavities. Hence no conclusion on the effect of microcavity culture on 
the CFU forming potency can be drawn.  
Figure 26 CFU Forming after 14 Days of Cell Culture on Microcavities. CFU scores indicate reduced 
potency for surface adherent cells (B) although the FACS profile shows higher CD marker 
expression (A). Data are represented as mean + SEM, n=3.  
As tested afterwards, trypsin apparently affects long term culture and thus reduces colony 
forming capability. Therefore the following experiments with mouse BM culture were carried 
out using accutase instead of trypsin for detaching the cells from the ECM microcavities. 
Accutase-detached HSCs yield a significantly higher CFU forming potential when directly 
compared to trypsinized cells although they display a similar cytometric profile (Suppl. Fig. 
37). FACS analysis was directly performed after detachment and recovering of cells. Possibly 
the surface molecule digestion resulting from the trypsinization was not fully preceded during 
cytometric analysis but impairs long-term CFU cell culture. 
4.4 Single Cell Analysis of Differentiation 
While the observed effects of microstructured substrates on the entire HSC population provide 
valuable insights, the applied integral analysis (FACS) could not distinguish between cells 
growing inside and outside the microcavities. Therefore HSC marker expression was 
additionally analyzed by individual adherent cells via immunofluorescence.  
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Figure 27 Single Cell Analysis of Differentiation. (A) Immunofluorescent single cell analysis of 
adherent cells revealed higher stem cells marker expression by HSC residing inside microcavities 
compared to those outside. (B) Image of fluorescent CD staining of HSC cultured on microcavity 
surfaces (DAPI – blue, CD133 – red, CD34 – cyan, scale bar 40 µm). Data are presented as mean + 
SEM; n=3. 
Distinct differences between cells residing inside and outside the microcavities were found 
(Fig. 27). For all ECM molecules around 96% for FN and even more approximately 99 % for 
Hep and Col I of HSCs adhering inside the microcavities maintained CD133 and CD34 
expression after seven days, whereas only 79 % for FN, 91 % for Hep and 97 % for Col I of cells 
adhering outside showed HSC marker expression. Within these populations, the fraction of 
cells expressing the early progenitor marker CD133, either together with CD34 or alone, was 
again higher inside the microcavities (91 % on FN, 98 % on Hep and Col I) as compared to cells 
growing outside (68 % FN, 90 % Hep, 94 % Col I). Interestingly, no pronounced dependence 
on microcavity size was observed for HSC expression of CD133 and CD34, which is why results 
obtained from different microcavity sizes were presented in a single graph (Fig. 27). 
These single cell results resemble the trends observed within the population level in chapter 
4.2.2., although these data are not directly comparable, since FACS and LSM analysis display 
different sensitivity to fluorescence intensities. Summing up, adhesion inside microcavities and 
hence higher obligation of adhesion receptors promote a more immature state of progenitors. 
4.5 Cell Cycling Dependency on Cytokine Level 
For further insight into the regulation of HSC behavior by spatial confinement, cycling was 
investigated at single cell level by repeatedly scoring DNA synthesis of cells on microstructured 
surfaces. FACS analysis on plane substrates again served as control. Additionally, since 
cytokine signaling is a critical parameter for the proliferation of HSC cultures and is known for 
its synergistic effect on adhesion-related signaling [80], another series of experiments was 
carried out using higher cytokine concentrations (30 ng in comparison to 10 ng each of TPO, 
SCF, and FL3).  
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4.5.1 Plane Surfaces  
HSC adhesion to ECM-coated planar surfaces for one day led to enhanced cell cycle entry in 
the case of FN or Hep (Fig. 28 B). This effect was further enhanced by increased cytokine 
concentration (Fig. 28 B). Compared to adherent cells, non-adhering HSCs always showed 
delayed cell cycle entry irrespective of the matrix coating and the cytokine concentration (Fig. 
28 A). After 3 days HSCs approached a constant cycling state until the end of culture (7 days). 
In this state cell cycling was no longer dependent on adhesive contacts of the HSCs for low 
cytokine concentrations (10 ng). At higher cytokine concentrations (30 ng), only about 50% of 
cells adhering to the FN or Hep layers replicated their DNA within 24 hours, compared to 
more than 70% of the non-adherent cells after a similar culture period, whereas around 75 % of 
cells on Col I synthesized new DNA independent of surface adherence (Fig. 28 A, B).   
Cells adhering to FN and Hep entered into the cell cycle earlier than cells in suspension or 
adherent to Col I, followed by a deceleration in the cycling kinetics of the adherent cells at 
later time points. These adhesion-related effects were further amplified by increasing cytokine 
concentration, suggesting an ‘inside out - outside in’ signaling mechanism through which 
bound integrins synergize with cytokines to increase cell proliferation as also reported by 
Lévesque et al. [81]. In contrast, antibody blocking experiments illustrated previously that HSC 
adhesion to FN via integrins induces proliferation inhibitory signals under culture conditions 
containing physiological cytokine concentrations [80]. However, this inhibition of adhesion 
receptor signaling was repressed by increasing cytokine concentration, which drives HSCs to 
enter S-phase. These results nicely display the synergistic action of adhesion- and cytokine-
related signals. Col I slowed down early cell cycle entry but at later time points accelerated 
cycling compared to FN or Hep independent of cytokine concentration (Fig. 28 A, B). Thus 
each ECM molecule has its own effect on the cycling machinery of HSC which is influenced by 
cytokine concentrations. In addition to the conjunction of the adhesion- and cytokine-related 
intracellular signal transduction involved in cell cycling, the ability of the ECM molecules to 
bind cytokines might be of further importance. As described in 2.1.4, tethered cytokines affect 
cell behavior in a different manner than soluble growth factors. FL3 and SCF both cytokines, 
which appear in vivo as soluble and bound isoforms, were added to this experimental setup 
and most probably bound partially to the ECM coating. Thereby they are available in solution 
and also display their action upon HSCs in a surface bound manner. In the case of SCF the 
soluble isoform is suggested to have a mobilizing effect on HSCs and to be growth promoting. 
In contrast the tethered isoform enhances adhesion and maintains immature HSC, reviewed in 
[163]. At the beginning of culture all cytokines are available in solution elevating integrin 
activation (‘inside-out’ signaling) leading to faster adhesion. In a second step, integrin-ECM 
binding cooperates with mitogenic growth factor action (‘outside-in’) [81]. This explains the 
increased DNA synthesis for FN and Hep adherent HSCs after one day of culture which is even 
more enhanced upon higher cytokine levels. Over time in culture cytokines diffused to the 
surface and partly bound to ECM molecules which for SCF (and similarly suggested for FL3 but 
not proved, yet [163]) may lead to enhanced adhesion, hence proliferation inhibition by 
integrin action [129] and maintenance viz. slower cycling of HSCs. This explains the lower DNA 
replication rate for adherent cells at high cytokine concentration after 3 and 7 days in culture 
compared to supernatant cells Fig. 28 B). For Col I at the beginning of culture adhesion related 
inhibition of proliferation due to the enlarged ligand density resulting from the Col I fiber 
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three-dimensionality might overbalance cytokine induced cycling. Due the 3D gel character of 
Col I, it might also adsorb and retain cytokines in higher amounts in contrast to FN and Hep. 
In that way, cytokines act upon HSCs on Col I surfaces in a more sustained manner. 
Furthermore, cytokines induce a dose-dependent receptor activation [172]. For example, higher 
concentrations of SCF initially cause a more rapid receptor internalization and extracellular 
cytokine depletion compared to lower concentrations [164]. Such processes are presumably 
boosted by the synergistic action of cell matrix adhesions leading to even higher cytokine 
exhaustion within the media, which then in turn permits the action of adhesion related 
proliferation inhibitory signals after cytokine reduction. Thus HSC  adherent to FN or Hep at 
30 ng conditions would consume the most cytokines within the shortest period of time 
explaining the initially high (after 24h) and later (3 and 7 d) lower rate of DNA synthesis 
compared to control cells or cells exposed to 10 ng cytokines. Concerning the high cytokine 
conditions on Col I surfaces; the partially adsorbed cytokines might result in a more sustained 
action upon HSCs, as described above, which led to higher proliferation rates after 7 days, 
when compared to FN and Hep and low the cytokine data. 
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Figure 28 DNA Synthesis on Planar ECM-coated Surfaces. (A) Comparison of the cycling rate between 
surface adherent and supernatant cells shows after one day an increased cycling for FN and Hep 
adherent cells. Col I adherence and suspension delay cell cycle entry. This effect is further clarified 
by increasing the cytokine concentration from 10 ng to 30 ng. After three and seven days FN and 
Hep adherence decelerates cycling compared to respective supernatant cells or Col I adherent 
HSCs. (B) To point out the differences the rate of DNA synthesis is compared between adhesion to 
the distinct ECM molecules. (C) After 24 h of BrdU uptake, cell cycling was determined by 
cytometric analysis. Data are represented as mean ± SEM (A, B), n=1-3. 
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4.5.2 Microcavities Reduce Cycling Frequency 
For the low cytokine scenario (10 ng), after three days in culture, HSC cycling inside FN 
microcavities was found to decrease with decreasing microcavity size, ranging from 
approximately 60% for the largest (80 µm) microcavities to approximately 30% for the smallest 
(15 µm). Cells adhering outside the microcavities showed 60% BrdU incorporation 
independent of cavity size. After seven days in culture, cell cycling was higher with 
approximately 70% of HSCs showing BrdU incorporation irrespective of microstructural 
constraints (Fig. 29 A). In this state cell cycling was no longer dependent on adhesive contacts 
of the HSCs for low cytokine concentrations. At higher cytokine levels (30 ng), DNA 
replication occurred in 50% to 60% of HSCs adhering inside microcavities after three days, 
independent of the cavity dimensions (Fig. 29 A). After 7 days, an increase of 50% to 70% BrdU 
incorporation into HSCs was observed as microcavity size increased. The significant reduction 
in cycling seen for cells grown in the smallest microcavities at low cytokine concentrations 
(10 ng) was not observed at higher cytokine concentrations (30 ng). For Hep and Col I similar 
tendencies are observed (lower proliferation with decreasing microcavity size, lower cycling 
rate inside microcavities compared to respective plane outside) however, not as pronounced 
(Fig. 29 A).  
In line with previous reports [80], and the results presented above for cycling rate on plane 
ECM substrates, adhesion to FN induces proliferation inhibitory signals under culture 
conditions with low cytokine concentrations. A cycling inhibitory effect is detected with an 
increase of the cell-FN–adhesion area inside small microcavities, which is suppressed in the 
presence of high cytokine levels, far beyond physiological conditions [74], as adhesion-related 
signals are overbalanced under these conditions.  
The changes in cycling rate, observed at the single cell level may lead to the pronounced effect 
on the overall culture population proliferation and differentiation described in chapter 4.3.2, 
which results from the exponential amplification of the cavity size-dependent cycling rates due 
to growth kinetics of the cells.  
This finding suggests that keeping HSCs in a three-dimensional arrangement of ECM ligands is 
critical to maintain the cells in a quiescent and multi-potent state. FN which is proved to play 
an important role in the homing process of stem cells  [82, 83] might also play the crucial part 
in maintaining HSC in an immature state inside the BM, as for the other BM-relevant ECM 
molecules tested in this setup (Hep and Col I) the proliferation inhibitory effects are not as 
pronounced. Although Col I might be considered for short-term cultures up to 24 h since it 
initially inhibited cell cycling (chapter 4.4.1). Or, cytokines are already introduced during Col I 
curing onto the PEMA surfaces which might provide stable bound growth factors to the cells. 
Of course, further ECM molecules which are suggested to be functionally important in the BM 
[165, 77, 66, 166] need to be examined for their ability to influence spatially confined HSCs. 
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Figure 29 DNA Synthesis Inside vs. Outside Cavities. Cell cycling was determined by 
immunofluorescence analysis after 24 h of BrdU incorporation (B). A decrease in HSC cycling rate 
occurs at the low cytokine concentration for FN adherent HSCs but is suppressed at higher cytokine 
concentration. For Hep or Col I no pronounced effect of microcavities as for FN is observed (A). 
Data are presented as mean + SEM. Color index in bottom panels B: BrdU – green, PI – red, scale 
bar 80 µm.  
4.6 Mice Repopulation of Microcavity Cultured HSCs 
Although, as previously shown (chapter 4.3.2), HSC cultured with small ECM-coated 
microcavities maintain their stem cell marker, their functionality remains to be proved in vivo. 
Competitive repopulation studies in mice are planned to verify if microcavity culturing 
increases repopulation capability.  
In a first trial, whole mouse BM was isolated and cultured onto FN-functionalized moulds with 
and without distance in between microcavities with the cavity sizes of 15 and 40 µm. Total cell 
expansion and the respective fraction of KSL+ cells was measured. For redesigned 
microcavities mouse BM cells expand double compared to cavities with distance in between 
(Fig. 30 A). Also the percentage of KSL+ cells is higher with 8 % for 15 µm cavities and 9 % for 
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40 µm cavities compared to 6 % and 5 %, respectively (Fig. 30 B). Hence, side by side 
microcavities show improved maintenance of KSL+ cells and will be used for future 
transplantation experiments.  
In a first repopulation experiment purified KSL+ cells from C57BL/6N mice were cultured onto 
functionalized redesigned microcavities and transplanted after 10 days into lethally irradiated 
SJL mice. Therefor, the microcavity sizes 15 and 40 µm were taken incl. control in suspension. 
The detached cells were measured for the amount of KSL+ and subsequently transplanted into 
irradiated recipient SJL mice at 1 x 105 cells plus 1 x 105 freshly isolated helper KSL+ from the 
transplanted mice. Repopulation was analyzed after 21, 36, 57, and 78 days. The cultured and 
the helper cells within repopulating cells were distinguished via surface CD45.2 (C57BL/ 6N) 
and CD45.1 (SJL) markers to prove the functionality of the microcavity cultured KSL+. Eleven 
weeks after transplantation cells from 15 µm microcavity culture increase in their contribution 
to approximately 84 % repopulation of SJL mice whereas repopulation is continuously 
decreasing for 40 µm and suspension cultured KSL to 55 % and 33 % respectively (Fig. 30). 
Thus the first trend shows functional HSCs after 10 days of culture within 15 µm microcavity 
confinement which outcompete freshly isolated cells as proved by in vivo competitive 
repopulation experiments.  
 
Figure 30 Expansion of KSL on Microcavities. (A) Whole mouse BM was grown for 14 days on FN 
functionalized microcavities. Highest proliferation of cells was achieved on redesigned 
microcavities. Besides, the percentage of primitive KSL cells was also highest within redesigned 
microcavity cultures (not shown). (B) Mouse KSL cells were grown on FN functionalized redesigned 
microcavity for 10 days and transplanted into mice for competitive repopulation. The contribution 
of KSL is highest for 15 µm microcavities cultured cells compared to 40 µm or control KSL 11 weeks 
after transplantation. (n=1) 
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4.7 Summarized Discussion of the HSC–ECM Relation 
Since the unique characteristics of the bone marrow stem cell microenvironment depend on a 
delicate balance of soluble and insoluble cues, a defined ECM-coated microcavity assay was 
used to investigate the interplay of cytokine signaling and adhesion-related signals in 
controlling HSC fate in vitro.  
The results presented here highlight the dependence of HSC proliferation upon microcavity 
size and demonstrate the important role of spatial confinement upon HSC cycling, when cells 
are grown on adhesive substrates. The observations made, support the idea of a spatially 
induced quiescent state over longer time periods inside the BM whereat the greater 
engagement of adhesion receptors as inside small microcavities is proposed to be one of the 
main mechanisms responsible for HSC maintenance. Additional contribution by paracrine 
signaling activated by cell-cell contacts and close proximity of residing HSCs as proposed for 
intermediate cavity size and redesigned microcavities and described previously [162, 167] might 
also play a considerable role in stem cell fate decisions. However, the results demonstrate that 
microstructured adhesive culture carriers can support HSC quiescence in vitro if the size of the 
constraining cavity is appropriate to host individual cells. Furthermore, the data indicate that 
in HSC cultures a minor local variation in the cycling rate, observed at the single cell level, 
leads to a pronounced integral effect on the overall culture population. Such effect most likely 
results from the exponential amplification of the cavity size-dependent cycling rates when 
considering the growth kinetics of cells.  
Figure 31 Balance of Cytokine Level and Adhesion in Cell 
Cycling. At moderate cytokine levels increasing adhesion overcomes cytokine stimulation of 
proliferation and inhibits cell cycling. Whereas adhesion related signals are overbalanced from high 
cytokine concentrations enhancing cell cycling. 
HSCs adhering to either FN or Hep entered into the cell cycle earlier than cells in suspension. 
In contrast cells adherent to Col I show delayed cell cycle entry. These adhesion-related effects 
for FN and Hep were further amplified by increasing cytokine concentration. Adhesion has 
been shown to synergize with the mitogenic action of cytokines but also to induce 
proliferation inhibiting signals [81, 80]. Considering the lower cycling rate of adhesion inside 
vs. higher cycling outside microcavities in a low cytokine scenario, this clearly proves the 
interconnection between adhesion- and cytokine signaling. At higher cytokine concentrations 
far beyond physiological range adhesion-related inhibition of proliferation is overbalanced 
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(Fig. 31). This statement suggests that the inhibitory effect of small adhesive microcavities on 
cell cycling manifests itself only at lower cytokine levels, resembling conditions found in the in 
vivo bone marrow stem cell microenvironment. At the beginning of culture cytokines promote 
adhesion and in turn adhesion to FN and Hep accelerates cell cycle entry – a process that is 
additionally supported by higher cytokine levels. Initial adhesion to Col I suppressed early cell 
cycle entry compared to FN and Hep which might be explained by the higher adhesion ligand 
density due to the three dimensional nature of Col I fibrils by this providing more adhesion 
inhibitory signals overwriting the cell cycle stimulation by cytokines. Later on, for all three 
ECM molecules the culture system balances itself at a steady state of cycling and non-cycling 
HSCs. Not only the concentration but also the coupling of growth factors to the provided ECM 
during culture most probably plays a considerable role in HSC cycling additionally supporting 
the observations made in chapter 4.5. As for the bound isoforms of SCF and FL3 a HSC 
maintaining and adhesion supporting role is suggested compared to the mobilizing and 
proliferation stimulating effect of the soluble isoforms [163]. In summary, higher adhesion 
receptor engagement inhibits cell cycling up to a certain cytokine concentration. Too high 
cytokine concentrations in turn overbalance the inhibitory adhesion-related effect and 
stimulate proliferation (Fig. 31). 
The finding of enhanced stem cell marker expression in response to restriction of the 
microcavity size suggests that keeping HSCs in a three-dimensional arrangement of ECM 
ligands might facilitate the conservation of their immature state in vitro. This observation is 
particularly important since HSCs in standard cell culture show a tendency to lose stem cell 
surface markers and differentiate [5]. Thus, it is quite likely that increasing the adhesive cell-
matrix contact area, and consequently the number of engaged integrins, is critical to maintain 
HSCs in a quiescent and multipotent state. 
Enhanced cytokine-driven proliferation is known to impair the expression of adhesion 
receptors and thereby reduces homing efficiency after transplantation [79]. Thus, the 
observation that engagement of adhesion molecules in a spatially defined manner at moderate 
cytokine levels decreases proliferation and differentiation may preserve integrin receptors and 
offer better repopulation capabilities.  
The preservation of stem cell markers during culture could also be relevant for gene 
transduction approaches. Most gene transduction strategies require cell cycle entry and this 
usually leads to loss of the stemness of cells. Microstructured culture carriers could potentially 
preserve the transduced subset of cells and optimize the efficiency of HSC gene transduction 
protocols. For example, it has been shown that after cytokine-driven retroviral transduction, 
late dividing cells with preserved CD133+ expression and carrying the transgene had the 
highest mouse-repopulation potential [168]. 
One factor, which hasn´t been considered in this work, but indeed plays an important role in 
stem cell fate decisions, is the surface elasticity or stiffness [124].  The BM with its diverse 
structures features a wide range of different elasticity’s, from soft stroma cells [169] to hard 
trabeculae [170]. It is hard to predict the niches surface mechanics since its exact position is 
not known, yet. But it has been found that during mobilization upon G-CSF treatment bone-
lining osteoblasts exhibit a flattened appearance with shorter projections into the matrix [171] 
and thus are stiffer compared to non-treated cells [169]. The different coated PDMS 
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microcavities presumably provide different elasticity because of the varying ECM layers. Col I 
is most probably softer than FN or Hep due to its gelling properties within aqueous solutions. 
This also might play a role for the different proliferation and differentiation patterns of HSCs 
seen for the diverse matrix coatings. Mechanical surface characteristics will be investigated and 
considered for future experiments. 
The functionality of this 3D microcavity setup is currently investigated in mice repopulation 
studies. The first trend shows a higher functionality of single cell microcavity cultured cells 
compared to suspension or multicell-microcavity culture, which will be further investigated. 
4.8 Future Prospects 
Thus for the homeostatic regulation of HSCs within the BM a tight balance between 
environmental signals is obligatory for the maintenance and differentiation of stem cells. 
Further aspects like matrix elasticity and of course more BM relevant matrix molecules, e.g. 
laminin, osteopontin, thrombospondin, hyaluronic acid and BM isolated ECM mixtures will be 
tested upon their functionality on HSC fate decisions. 
Single cell tracking of HSCs cultured on microcavity platforms will give additional information 
about the divisional behavior of the cells in dependency on matrix and confinement and allows 
on one hand to follow several generations of daughter cells including their fate decisions and 
on the other hand for computational modeling of their behavior to strengthen predictions of in 
vivo events e.g. during repopulation after chemotherapy. 
One first functional repopulation study of microcavity cultured mouse HSC showed a higher 
repopulative ability of single-cell FN microcavity-cultured cells compared to multi-well or 
suspension cultured HSCs. This of course has to be repeated and proved in ongoing 
experiments. 
Thin film lithographic attempts to make the microcavity culture platform more qualitative for 
quantitative cell assays like FACS or CFU weren’t sufficiently successful in blocking protein 
binding and hence cell attachment in between microcavities. Therefore the microcavity 
moulds were redesigned with the distance in between as small as possible to force the HSCs to 
stay inside the confining microcavities. The effects on HSC proliferation and differentiation 
seen within these redesigned microcavities resembled the trends described for microcavities 
with distance in between, but appeared not as pronounced. This might be due to paracrine 
signaling in between HSCs residing in close proximity in microcavities next to each other 
interacting on the cycling behavior. Therefore further strategies will be applied in future for 
surface passivation in between microcavities. Thick PEG hydrogel layers in between 
microcavities for protein blocking are one approach. Another trial yields the usage of tagged 
ECM or signaling proteins which bind to a priory microcavity embossed linker molecule. Such 
strategy has the additional advantage of the correct orientation of the immobilized protein.  
  Summary
 
7  Low cytokine conditions: 10 ng each; High cytokine conditions: 30 ng each TPO, SCF, and FL3 
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5 Summary 
In vivo geometrical constraints ranging from single‐ to multi‐cell compartments are present in 
the stem cell niche. The aim of this thesis was to (i) examine the impact of geometry on HSC 
proliferation  and  differentiation  and  (ii)  the  importance  of  soluble  cytokines  on  geometry 
induced  effects.  Therefore  a  microcavity  culture  system  was  designed  to  recapitulate 
geometrical constrains found in vivo that accommodated single cells (10 and 15 m diameter of 
cavity) and multi‐cell‐groups (30, 40, and 80 m). To facilitate cell attachment, the wells were 
coated with bone marrow relevant ECM (fibronectin, collagen I, heparin) and the system was 
supplemented with a range of growth factor concentrations. This setup allowed for studying (i) 
the dependence of HSC proliferation and differentiation on microcavity size, (ii) the extent of 
integrin activation on cell cycle progression, (iii) the interplay between adhesion‐ and cytokine 
related signaling on cell proliferation and stem cell differentiation. 
Cells in single‐cell microcavities were exposed to more adhesion ligands (i.e. ECM) due to the 
3D nature of  the  tight  fitting wells  compared  to multi‐cell wells or plane  surfaces.  In  small 
cavities  a  greater  engagement  of  adhesion  receptors  reduced  the  number  of  cycling  and 
proliferating cells when compared to multi‐cell compartments or 2D substrates. Inhibition of 
proliferation  due  to  adhesion  was  only  observed  at  low  cytokine  conditions7.  Cytokine 
concentrations  well  above  the  physiological  range  masked  geometry  based  effects.  Thus 
adhesion and cytokine signaling have an antagonistic effect on cell behavior at 3 and 7 days in 
culture.  However,  during  the  first  24h  in  culture,  adhesion  and  cytokines  also  showed 
synergistic  effects  by  inducing  early  cell  cycling.  HSC  initially  adhering  to  fibronectin  or 
heparin entered cell cycle early compared to cells in suspension or adherent to collagen type I. 
This  observation  could  be  further  augmented  by  high  cytokine  concentrations.  At  the 
beginning of culture, cytokine signaling promoted adhesion and the adhesion signaling in turn 
cooperated with cytokine receptor signaling, which led to enhanced cell cycling. Collagen type 
I  fibrils on contrast provided more adhesion sites due to their 3D nature compared to FN or 
Hep,  thereby  possibly  facilitating  adhesion‐related  inhibitory  signals,  which  overwrote 
cytokine  signaling  and  inhibited  early  cell  cycle  activation.  Furthermore,  initially  boosted 
proliferation  of  fibronectin  and  heparin  adherent  HSCs  presumably  led  to  early  cytokine 
exhaustion  and  resulted  long‐term  in  a  lower  cell  cycling  rate.  In  contrast,  the  gel‐like 
collagen I  substrates probably  adsorbed  and  retained  cytokines, which  sustained higher  cell 
cycling at prolonged culture. 
Considering  differentiation,  the  highest  expression  rate  of  the  stem  cell markers CD34  and 
CD133 was found for single‐cell microcavities for all three investigated ECM molecules. Hence 
confinement of HSCs preserves a more immature stem cell state.  
The defined 3D HSC culture system described in this work allows the systematic investigation 
of single ECM and signaling molecules and combinations thereof without the complexity of co‐
culture  or  in  vivo  studies.  The  results  suggest  that  confinement  of HSCs  leads  to  reduced 
proliferation in vitro, keeping cells in a more immature state. The developed setup is believed 
to become  a useful  in  vitro HSC  assay platform  thus  strengthening  the predictive power  of 
human HSC culture studies.   
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Theses  
(1) Extracellular matrix (ECM) molecules can be covalently bound to poly(ethene-alt-
maleic anhydride) (PEMA) functionalized poly(dimethylsiloxane) (PDMS) 
microcavities. 
(2) Poly ethylene glycol (PEG) and Polyoxazoline (PMOXA) thin layers are not sufficient to 
block protein binding and thereby doesn’t prevent cell adhesion. 
(3) The 3D microcavity setup provides an easy access and is therefore suitable for analytical 
methods such as cytometry and quantitative microscopy. 
(4) Hematopoietic stem cells (HSC) adhere, proliferate and differentiate within fibronectin 
(FN), collagen I (Col I), and heparin (Hep) coated microcavities. 
(5) HSC adhering within small single cell microcavities functionalized with either FN, Hep, 
or Col I proliferate and differentiate less compared to cells in suspension, or bigger 
multi cell microcavities. 
(6) ECM adhesion of HSC keeps HSC in a more immature state as they express more stem 
cell surface markers CD34 and CD133 than cell in suspension. This effect is further 
amplified by adhesion inside microcavities. 
(7) The higher the adhesion of HSC the more HSC proliferation and differentiation is 
inhibited. 
(8) The higher the cytokine concentration the more HSC proliferation and differentiation 
is stimulated. 
(9)  The balance between adhesion and cytokine concentration tightly regulates cell 
cycling. 
(10) Soluble cytokines initially promote activation of adhesion receptors which in turn 
synergizes with growth factor signaling resulting in an early cell cycle start of HSC. In 
turn, once the culture system equilibrates, adhesion vs. cytokine signaling show 
antagonistic effects on cellular cycling.  
(11)  HSC cultured in single fibronectin-coated microcavities are functional in competitive 
repopulation of lethally irradiated mice. 
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6 Appendices 
6.1 FACS Principle 
Cells in suspension single-filed in a fluidic stream (via hydrodynamic focusing) get illuminated 
by laser light whereby they scatter light and emit fluorescence which is detected by a number 
of detectors (one in line with the light beam: forward scatter FSC, and several perpendicular: 
sideward scatter SSC and one or more fluorescence detectors) and converted into digital values 
displayed at the computer. The FSC correlates with the cell volume and the SSC depends on 
the inner complexity e.g. shape of nucleus, granularity, or membrane roughness. These two 
parameters are used to set the final cell population to be analyzed. The fluorescence is 
displayed in dependency on the relative intensity for each cell (Fig. 32).  
 
 
Figure 32 FACS Principle. Cells are gated 
according to their phenotype (volume and 
granularity). (B) Within a gated 
population cells can be distinguished with 
their fluorescence intensity. 
 
6.1.1 HSC Staining for CD Marker and Cell Cycle Kinetics 
For FACS detection of surface CD marker supernatant and adherent cells were separately 
harvested into FACS tubes as described above, counted, blocked with 10 % FCS/ PBS for 30 
min, resuspended in 80 µl antibody solution with the respective antibodies diluted in buffer 
0,5 % FCS/ PBS (respective dilution in table 3), incubated for 10 min in the dark at 4 °C, washed 
with 1 ml buffer, and resuspended in 300 µl for detection. Staining was immediately quantified 
(changed CD marker profile was observed after overnight storage). 
For immunofluorescence microscopy, cells were prefixed with 2 % PFA, directly put into the 
cell media, for 2 min, blocked 3 x 5 min with 10 % FCS/ PBS, labeled with the desired CD 
antibody for 10 min at 4 °C, washed 3 x 5 min with 1 % FCS/ PBS, labeled with the respective 
secondary Alexa Fluor antibody for 45 min at room temperature, washed again 3 x 5 min with 1 
% FCS/ PBS, and finally covered with mowiol. Samples can be stored in the fridge for a couple 
of days. 
For the analysis of cell cycle kinetics, cells were incubated with 20 µM BrdU 24 h prior fixation 
in ice-cold 70 % ethanol for 30 min on ice. After fixation samples were washed 3 x 5 min in ice-
cold PBS, and incubated with 0,5 % RNAse for 30 min at 37 °C (only for FACS, not 
immunofluorescence) to avoid possible RNA staining with PI. For cell permeabilization and to 
unwind the DNA strands for better antibody accessibility cells were treated with 2N HCL and 
0,5 % Triton X-100/ PBS for 30 min at room temperature. Cells were then washed 3 x 5 min 
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with buffer 0,5 % FCS/ PBS to remove all HCL (otherwise the antibody might be destroyed), 
stained with the primary anti BrdU antibody 30 min in the dark at room temperature, washed 
3 x 5 min with buffer, incubated 45 min at room temperature with secondary Alexa Flour 488,  
washed again, incubated with 2 µg/ ml PI in PBS for 30 min, washed, and either mounted with 
mowiol for immunofluorescence microscopy or resuspended in 300 µl buffer for FACS analysis. 
6.1.2 Apoptosis Test 
The viability of HSCs was proved via freshly prepared 0,01 mg/ ml FDA (viable cells) 
counterstained with 2 mg/ ml PI/ PBS (dead cells) and immediately detected with FACS and 
immunfluorescence microscopy. Within the HSC population gate in FACS 99 % of cells are 
viable. Immunfluorescence microscopy showed approximately 90 % viability (Fig. 33) for all 
surfaces and microcavity designs. 
 
Figure 33 Proof of Cell Viability. HSC show more than 99 % viability with FACS gating strategy (A, B). 
Approximately 90 % of the cells are alive within immunfluorescent images (C, green) independent 
of cavity size. (n=1, green FDA, red PI, scale 80 µm, data presented as mean± SD)  
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Figure 34 Cell Viability on redesigned microcavities. Immunfluorescent microscopy shows more than 
90 % viable cells (A, B green) growing inside microcavities. FACS gating provides ca. 99 % HSC 
alive. (n=1, green FDA, red PI, scale 80 µm, data presented as mean ± SD) 
6.2 Differentiation and Proliferation on Redesigned Microcavities 
Figure 35 Differentiation after 14 Days of Culture. (A) Overall Proliferation shows no dependency of 
CD marker expression on microcavity size. HSCs cultured on Hep surfaces show decreased 
proliferation compared to FN or Col I cultured cells. (B) Separately viewed adherent and 
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supernatant cell fractions show higher maintenance of stem cell marker expression for surface 
adherent cells. Data are represented as mean + SEM, n=3-4.  
No dependency of proliferation or CD marker expression on microcavity size was seen after 
14 d of culture. However, a higher fraction of surface adherent HSC still expresses stem cell CD 
marker as compared to cells in the supernatant (Fig. 35).  
6.3 Colony-forming Capability of Microcavity Cultured Cells 
As already stated above, after seven days of microcavity culture cells show similar numbers of 
CFUs are scored for all surfaces independent of matrix, microcavity size or adhesion, although 
there are less CD marker negative cells within the adherent fraction (Fig. 36). 
Figure 36 CFU Forming Capability after 7 Days in Culture on ECM Microcavities. Similar CFU rates are 
scored for all surfaces (B) with no dependency on matrix, spatial restriction or adherence (A). Data 
are represented as mean + SEM, n=3.  
6.4 Effect of Trypsin on HSC Properties in Long Term Culture 
Since trypsin hydrolyzes surface proteins during detachment procedure of cells and as 
suggested in the results and discussion part of this work, it might have a harmful long term 
effect on HSC concerning their stem cell potential. Therefore accutase an alternative for 
trypsin was tested in direct comparison for FACS staining and CFU-forming capability. No 
differences were observed between accutase (10 min) and trypsin treatment (4 min) within the 
FACS profile of CD marker staining (Fig. 37). However, after 14 days CFU cultured cells treated 
with accutase show a much higher colony forming ability compared to trypsinized ones. Thus 
trypsin seems to affect the long term potential of HSCs. It is therefore suggested to use 
accutase for further in vivo studies on HSC cultures within microcavities.  
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Figure 37 Trypsin Effect on CFU Forming Capability. FACS Profile (A) and CFU forming (B) were 
compared after trypsin or accutase treatment to detach cells from same donor from similar 
surfaces. Cells treated with accutase have higher CFU count compared to trypsinized cells (B), 
although the FACS profile only shows slightly decreased CD34+/ CD133+ (approximately 5%) 
numbers for the trypsinized HSC compared to accutase (A). (Data are presented as mean of a 
triplicate trial for one donor ± SEM) 
6.5 Surface Functionalization with SCF 
Glass cover slips were cleaned (70 °C for 10 min in H2O2, NH3, and MilliQ water, 1:1:5 
respectively) and aminosilanized 2 h in 20 mM 3-aminopropyl-triethoxysilane / isopropanol / 
MilliQ 9:1 solution, and dried for 1 h / 120 °C. The cover slips were immediately spincoated with 
0.16 % poly(octadecene-alt-maleic anhydride) (POMA) / tetrahydrofuran (THF), dried again 
2 h/ 120 °C for anhydrite recovery of the POMA and linkage to the surface. To wash away 
unbound POMA the cover slips were washed twice in THF.  
For spacer coupling to the POMA cover slips the tert-butoxycarbonyl (Boc) PEG7 spacer was 
deprotected by stirring 2 h in dichloromethane and trifluoroacetic acid (TFA) in the absence of 
air and following removal of TFA in the rotary evaporator. The PEG7 was then dissolved in 
borate buffer (0.1 M) at a solution concentration of 10 mM, pH 8.0. Freshly annealed (2 h at 
120 °C) POMA-coated cover slips were incubated with the PEG7 solution over night at room 
temperature, rinsed 3 times in MilliQ, dried under nitrogen and annealed again 2 h at 120 °C to 
convert the formed PEG7 amide into the stable imide. 
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The SCF was immobilized for 3 days onto freshly annealed POMA or POMA/ PEG7 cover slips. 
Prior to SCF immobilization POMA/ PEG7 was activated on ice for 1 h using freshly prepared 
sterile filtered 50 mM 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) and 25 mM N-
Hydroxysulfosuccinimide (Sulfo - NHS) solved in 1/ 15 phosphate buffer, pH 7.4, washed twice 
in MilliQ and subsequently coated with SCF/ PBS. Unbound SCF was removed by washing 
several times in PBS. Before cell culture SCF-coated coverslips were preincubated with CellGro 
medium over night.  
HSCs were cultured in CellGro media supplemented with 10 ng each thrombopoietin (TPO) 
and FMS-like tyrosine kinase 3 ligand (FL3). For control SCF was added in solution in the same 
amount as immobilized on the surface though having the same amount of SCF/ well for each 
setup (Tab. 5). 
TABLE 5 Immobilization Concentration of SCF. Values were acquired by measurement of radiolabeled 
SCF by Tina Lenk and Juliane Drichel in our lab [130]. 
SCF/ Well Surface Density Immobilization Concentration (µg/ ml) 
SCF [ng/ well] SCF [ng/ cm2] POMA POMA/ PEG7 
20 15.3846 0.722 2.314 
30 23.0760 1.237 5.598 
6.5.1 Analysis of the HSCs Grown on Immobilized SCF 
On SCF-coated cover slips HSCs were cultured for 10 min, 1 d, 3 d, and 7 d and analyzed for 
proliferation, c-kit receptor expression, and SCF availability. All cells were collected after the 
desired time point and counted.  
For detection of surface c-kit cells were washed and labeled for flow cytometric analysis 
(FACS) using anti-CD117 allophycocyanin (APC) 10 min at 4 °C in the dark.  
Receptor activation was determined via Elisa of the phosphorylated c-kit. HSCs were lysed 
5 min on ice in cell lysis buffer supplemented with 1 mM phenylmethylsulfonylfluorid (PMSF) 
to prevent proteases from digesting the protein. The cell material was then ultrasonicated for 
10 s and centrifuged 10 min 4500 rpm, thus the protein was enriched in the supernatant, which 
was then deep-frozen at 80 °C until analysis. For analysis the cell lysate was diluted in dilution 
solution (1:1), pipetted and incubated at 4 °C over night in the anti-c-kit-coated Elisa plate. As 
zero control dilution solution was used. After 4-fold rinsing with wash buffer the lysate was 
incubated 1 h at 37 °C with biotinylated anti-phosphotyrosine antibody to detect the activated 
c-kit. After washing, the samples were incubated with horseradish peroxidase (HRP) 
streptavidin labeled secondary antibody for 30 min at 37 °C. After washing again, 
tetramethylbenzidine was added as substrate for the HRP for 30 min at room temperature 
(RT). Subsequently stop solution was added and the optical density of the wells was measured 
at λ=450 nm within following 30 min (Spectral Photometer incl. Magellan Software), which 
correlates to the amount of protein in each well.  
SCF availability and surface stability was measured via Elisa of the concentration in the 
medium after HSC culture. After HSC detachment the cell suspension was centrifuged and the 
supernatant was deep-frozen at -80 °C until analysis. As control and internal standard SCF was 
diluted at different concentrations (3, 2, 1, 0.5, 0.3, 0 ng/ ml) in the manufacturers dilution 
solution. The sample medium was diluted 1:10 in dilution solution. Samples and controls were 
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incubated over night at 4 °C in the anti SCF coated Elisa plate, washed four times, incubated 
with the biotinylated SCF detection antibody 1 h at RT, washed again, incubated with HRP 
streptavidin secondary antibody 45 min at RT, TMB was added, after 30 min stop solution was 
pipetted into the wells, and photometrically measured at λ=450 nm to determine the SCF 
concentration. 
6.5.2 SCF Immobilization and its Kinetics 
Many HSC influencing cytokines are presented in a membrane anchored fashion inside the BM 
to maintain stem cell properties, e.g. SCF and FL3 [111, 109]. Immobilization of these factors 
might prevent in vitro differentiation and allow for stem cell expansion, plus basic 
understanding of these mechanisms.  
Therefore, SCF was immobilized either onto hydrophobic POMA-coated cover slips to achieve 
very strong and covalent attachment of SCF or to POMA/ PEG7 functionalized culture carriers 
for covalent binding but better accessibility for the HSCs due to the flexible PEG7 spacer 
(Fig. 7). For comparison, SCF was directly given into the cell media in the same concentration 
per cell culture well as for the immobilized cytokine. The surface stability, the availability in 
solution of SCF, and the according cell behavior (proliferation, c-kit surface expression and 
activation, and differentiation) were measured.  
Elisa measurement of the SCF content in the media after 7 d of cell culture proved the cytokine 
to be stably immobilized on the POMA and POMA/ PEG7 surfaces. The concentration of SCF 
presented in solution slightly decreased over time but was still available after 7 d culture 
period (Fig. 38 A). However, HSC proliferation didn´t increase with increasing amount of 
immobilized SCF irrespective of the co-polymer coating compared to SCF presented in 
solution (Fig. 38 B). Thus, there is either not enough immobilized SCF or the active site of the 
cytokine is not detectable for the HSCs. As already mentioned in chapter 3.2, radioactive 
labeling of SCF proved the cytokine to be immobilized onto the POMA and POMA/ PEG7 
surfaces [130]. Presumably the active side of the SCF which is recognized by its receptor c-kit is 
impeded by the covalent binding to the co-polymers, even though the PEG7 spacer was 
expected to allow better accessibility to the cytokine. The c-kit active core of the SCF dimer 
contains lysine residues which also bind to the anhydride moiety of the co-polymer [129] and 
thereby are probably blocked for receptor recognition. 
Figure 38 SCF Surface Stability/ Availability and SCF Dependent Proliferation. (A) Elisa of the amount of 
SCF in cell media after 10 min, 1 d, 3 d, and 7 d of cell culture proves the immobilized protein to be 
stable, compared to amount of SCF presented in solution, which is available during the whole 
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culture period. (B) Proliferation of HSCs correlates with the solution concentration of SCF in the 
cell culture media. Immobilized SCF in contrast does not affect HSC expansion. Data are 
represented as mean + SEM, pictures (right) are modified after [130]. 
No impact was seen for the surface expression of c-kit (Fig. 39 A) during culture of HSCs on 
immobilized SCF. In contrast to soluble SCF, that reduces c-kit surface expression from 80 % 
to 20 % within 10 min of culture (Fig. 39 B). Surface expression was recovered after 3 d. The c-
kit receptor is not recycled after activation but requires new peptide synthesis [172] which 
explains the rather long time for surface reappearance in response to SCF stimulation. After 3 d 
the highest receptor activation was detected for HSC stimulation with soluble SCF and 
decreases by 40 % after 7 d (Fig. 39 C). As shown in Fig. 38 A, the amount of SCF decreases 
over time which then leads to less receptor activation although approximately 95 % of HSC 
exhibit surface c-kit after 7 d (Fig. 39 B). Thus HSCs express a certain amount of c-kit on their 
surface, once it gets activated and internalized it takes some time (3 d) until the cells adjust the 
amount of surface c-kit to the available SCF in solution. The same vice versa, when the 
available SCF gets less, it takes some time until the surface c-kit expression is adapted. No 
receptor activation could be measured for HSCs cultured on immobilized SCF (data not 
shown) which underlines the assumption of non-active SCF on the surface.  
Figure 39 c-kit Surface Expression and Activation. (A) The surface c-kit expression of HSC stays 
unaffected upon culture on POMA or POMA/ PEG7 in contrast to (B) the 60 % decrease of c-kit 
surface expression after 10 min when SCF is presented in solution, which then increases steadily to 
almost 100 % after 3 days. (C) Maximum activation of c-kit was observed after 3 days in culture with 
SCF presented in solution. For the surface immobilized no c-kit activation was detected (data not 
shown). Data resemble one trial performed in triplicate.  
Thus SCF in solution positively affects HSC proliferation and effectively leads to receptor 
internalization, activation and re-expression. In contrast covalent immobilization of SCF to 
POMA or POMA/ PEG7, although detectable and stable, prevents receptor recognition and is 
therefore not sufficient for the maintenance of human HSCs in vitro. The accessibility to the 
active core of SCF ought to be provided by a biomaterial for successful cell culture.   
6.5.3 c-kit Expression Kinetics and HSC Differentiation  
Surface c-kit expression of HSC is reduced from approximately 90 % to ~ 10 % after 10 min of 
stimulation with soluble SCF. After 1 d receptor expression recovers up to 50 % and is fully 
available on the surface 3 d after stimulation (Fig 40 A).  
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Figure 40 Surface Expression Kinetics of c-kit and HSC Differentiation. (A) Surface c-kit was reduced 
from approximately 90 % to approximately 10 % after 10 min. After 1 day in culture HSCs recovered 
their surface c-kit expression up to 50 %, and up to 80 % after 3 days. (B) CD 34 and CD 133 
expression profile after 7 days of HSC culture on immobilized SCF or with SCF in solution 
(control). With increasing SCF amount in solution higher number of CD negative cells was 
observed compared to cells cultured on immobilized SCF. No differences were seen between POMA 
and POMA/ PEG7.  Data are presented as mean ± SEM. 
The analysis of CD marker expression after 7 d in culture upon stimulation with different SCF 
concentrations in solution (ctrl) or immobilized shows increasing CD negative cells with 
increasing SCF amount in solution (from 3 % to 10 %); in contrast to surface immobilized SCF 
with only ~4 % CD negative cells. Whereby, no difference was observed for the different co-
polymer coatings (POMA or POMA/ PEG7) (Fig. 40 B). 
Short Discussion on the Growth Factor Immobilization 
For better understanding of the various cytokine actions within the BM, immobilization of 
these onto biomaterials may exhibit insights into their in vivo kinetics.  
The kinetic of action of soluble SCF on HSCs revealed c-kit internalization within 10 min of 
stimulation with maximum receptor activation after 3 days in culture. In contrast, immobilized 
SCF didn´t impact cell behavior, which is suggests the covalent binding of the active core of 
the cytokine to the co-polymer and thereby prevented the recognition by its receptor c-kit. 
Thus other immobilization strategies need to be applied. Adsorption of SCF to surfaces might 
lead to better accessibility for the HSC [173] but is not stably bound to the surface; it might get 
ripped off the surface by the HSCs and get internalized displaying same actions upon cell 
behavior as the soluble isoform. Therefore, a covalent anchorage of the non-active site of the 
SCF to a biomaterial is necessary. Lutolf et al used the coupling of Fc-chimeric cytokines to 
ProteinA adsorbed hydrogels for functionalization [136] which he proved functional for mouse 
HSCs. Another possibility for active immobilization of POMA or PEMA co-polymer-coated cell 
culture carriers would be the application commercially available polyhistidine (his) tagged 
SCF. The his-tag (typically 6 x his) is fused to the c-terminus of the SCF and can be coupled to 
the anhydride moiety of the co-polymer. Such his-tag approach will be part of future 
experiments on immobilized growth factors for stem cell maintenance and proliferation. In 
combination with the microcavity culture carrier and/ or immobilized ECM such strategy of 
growth factor presentation is proposed to disclose further insights into stem cell fate decisions. 
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